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ABSTRACT OF DISSERTATION
EFFECT OF SEASON AND NUTRITION ON INSULINEMIC RESPONSES IN
INSULIN DYSREGULATED HORSES
Insulin dysregulation (ID) is the main risk factor for the development of hyperinsulinemiaassociated laminitis (HAL). ID in the equid has been extensively researched; however,
recommendations for diagnosing and managing ID horses have originated from work
completed in other models, such as the ID pony and healthy horse. Therefore, our overall
objective was to improve current diagnostic tools and nutritional management strategies
by investigating the effect of season, the fed and fasted state on the oral sugar test (OST)
and dietary nutrient content on insulinemic responses in the ID horse. To address this, four
main objectives with three specific aims were examined. (OB1) To determine if season
effects insulin concentrations in the ID horse. ID horses’ morphometric measurements did
not change across season; however, seasonal changes in basal (T0) and post-OST (T60)
insulin concentrations were detected. ID horses had higher T0 and T60 insulin
concentrations in the spring compared to the fall and summer and winter had higher T60
insulin compared to the fall. Seasonal changes should be considered when diagnosing and
monitoring ID status. (OB2) To determine if a higher (HD) dose of oral sugar would
improve the diagnostic ability of the OST. (OB3) In addition to a higher dose, the fed (FE)
and fasted (FA) state prior to the OST was examined to determine if fasting has an impact
on basal and post-OST insulin concentrations. ID horses had higher insulin concentrations
compared to NID for all OST performed. There were no differences between the low dose
and HD OST for ID horses. ID basal insulin for FE was higher vs. FA OST, but FE or FA
post-OST insulin was not different in ID horses. Finally, (OB4) investigated ID horses’
insulinemic responses to varying nutrient concentrations, in order to improve current
nutritional recommendations for ID horses. ID horses had greater insulin responses
compared to NID horses for all dietary treatments. NSC appears to be the main driver in
the postprandial insulinemic response in the ID horse. ID horses appear to have threshold
for pure sources of NSC greater than 0.1 g/kg BW. This body of work added to the current
understanding of how-to diagnosis, monitor, and nutritionally manage ID horses.
KEYWORDS: Insulin dysregulation, equine metabolic syndrome, nonstructural
carbohydrates, insulin, oral sugar test, season
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CHAPTER 1.
1.1

LITERATURE REVIEW

Equine Metabolic Syndrome (EMS)
Equine Metabolic Syndrome (EMS) was first described in 2002 when the

association of obesity in mature horses and risk of laminitis was becoming more evident 1.
Johnson likened EMS to that of human metabolic syndrome due to similar characteristics
such as, insulin resistance (IR), increased obesity, hypertriglyceridemia, hyperleptinemia,
hypertension, and increased inflammation 2. Furthermore, the association between EMS
and the predisposition to laminitis was strengthened by two studies that induced laminitis
in healthy horses and ponies with experimental insulin infusion 3,4. Since then, researchers’
work and understanding of this complex syndrome has advanced and thus, the terminology
as well. In 2010, EMS was characterized by increased general or regional adiposity, (IR),
and the predisposition to laminitis 2. However, not all EMS horses have IR, which is when
the term insulin dysregulation (ID) replaced IR in the collection of risk factors for EMS 5,6.
ID broadly describes the abnormal interrelationship between glucose, insulin, and lipids,
and is a collective term for both basal and postprandial hyperinsulinemia, as well as tissue
insulin resistance 7. Finally, and most recently, the Equine Endocrinology Group (EEG)
now describes EMS as a collection of risk factors (stated above) for hyperinsulinemiaassociated laminitis (HAL) 8 with ID being the primary feature across all EMS phenotypes
(Figure 1). With new phenotypes of EMS gaining recognition (i.e., lean horses with ID),
not all original characteristics proposed by Johnson fit each individual horse1. Thus, the
classification and diagnosis of EMS is less frequently used and horses with risk factors for
HAL are now referred to as ID. With ID encompassing both hyperinsulinemia and tissue
insulin resistance, there are multiple ways to diagnosis a horse with ID.
1

1.2

Diagnostic Tests for Insulin Dysregulation (ID) in Horses
ID has 2 components – 1) hyperinsulinemia and 2) tissue insulin resistance.

Therefore, the diagnostic tests for these branches differ (Figure 2) 8. With tissue IR,
controlling delivery of exogenous glucose and insulin removes the variability associated
with the enteroinsular axis, or the gastrointestinal cascade of intestinal hormones and
digestion and absorption of feedstuffs 7,9; thus, allowing focus on tissue IR. Some of these
tests are cumbersome and can only be conducted in a research setting, like the
hyperinsulinemic-euglycemic clamp and the frequently sampled insulin glucose tolerance
test (FSIGTT) with minimal model analysis 6. However, two other IR diagnostic tests,
insulin response test (IRT)

10

and combined glucose insulin test (CGIT)

11

are used to

measure IR successfully. The CGIT, also known as the insulin tolerance test (ITT),
procedure measures basal insulin and glucose followed by the IV injection of glucose (150
mg/kg BW) and insulin (0.1 IU/kg BW). Blood glucose and insulin are measured again at
45 and 75-minutes post-IV injection. For diagnosis of ID, hyperinsulinemia, and a slow
return to baseline glucose 7,11 will be seen. While these types of diagnostics provide useful
information and status of an individual animal’s insulin sensitivity, tests that involve the
consumption of an insulinotropic feedstuff mimic the sequence of events that occur during
a natural metabolic response. Quantifying this response is done by using dynamic oral tests
such as the oral glucose test (OGT) and the oral sugar test (OST), which are used to
diagnosis postprandial hyperinsulinemia 12,13.
For diagnosing hyperinsulinemia there are two avenues, basal insulin, and dynamic
testing. Horses with basal insulin < 20 µIU/ML are considered non-insulin dysregulated;
whereas horses with basal insulin 20 – 50 µIU/ML are considered ID-equivocal and > 50
2

µIU/ML are considered ID 8. While basal insulin has appeared sufficient to diagnosis
hyperinsulinemia 14,15 it does not quantify the postprandial response to oral carbohydrates
16

and not all ID horses have basal hyperinsulinemia 14,17,18. Therefore, dynamic tests that

assess both the basal and postprandial response are recommended to diagnosis
hyperinsulinemia 8.
The OGT was developed for countries that do not have readily available Karo Light
Corn Syrup 5, which is used in the OST. The OST has gained wide popularity as the main
diagnostic test for ID due to its simple protocol and that both veterinarians and owners can
perform the test with ease. The protocol for the OST consists of collecting a basal blood
sample for insulin and administering Karo Light Corn syrup at a dose 0.15 ML/kg BW and
collecting another blood sample 60-minutes post-OST. If post-OST plasma insulin
concentrations are > 45 µIU/ML at 60 minutes, horses are considered ID.
The OST has had agreement with area under the curve (AUC) for glucose with the
CGIT and FSIGTT 15; and the results for the IV glucose tolerance test 12. In addition, the
OST has had acceptable repeatability at 75-minutes post-OST

19

recommendations are for evaluating insulin at 60-minutes post-OST

8,20

, but current
and that was

shown to have poor repeatability 21. However, the OST does have good reliability 17 . Poor
repeatability could be due to outside factors such as individual horse variation 12,22, intraand inter-assay variation

23,24

, and other environmental factors; however, the OST is still

the most recommended diagnostic test for ID 8.
Since the development of the OST, like all diagnostic test, improvements have been
made. First, the OST was developed using an overnight fast 12; however, this is not always

3

practical. Most horses are managed on pasture and owners are not always able to comply
with fasting protocols. In addition, fasting can stimulate stress, which will affect basal
insulin and post-dynamic testing insulin concentrations 6. The OST was performed in
healthy ponies either kept on pasture or after an overnight fast

17

. While significant

differences were found in both fed and fasting conditions to the OST, fasting exaggerated
insulin levels that would most likely affect diagnosis. As stated previously, the reliability
of the OST was acceptable due to the discriminatory power seen in the presence or absence
of oral sugar. Thus, both fasting and fed conditions can be used interchangeably when
standardization of OST methods are followed. With fasting exaggerating insulinemic
responses to the OST, researchers hypothesized that a greater amount of sugar provided in
the OST may improve the performance and repeatability of the OST 17.
Previously laminitic ponies and non-laminitic ponies received 3 OSTs with varying
oral sugar doses of 0.15, 0.30, and 0.45 ML/kg BW 21. Both groups of ponies were fasted
overnight and received all 3 doses 1-week apart and blood was collected at baseline and up
to 120-minutes post-OST. Insulin concentrations for 0.15 and 0.30 ML/kg BW were not
different; however, 0.45 ML/kg BW was greater compared to both lower doses at 60minutes post-OST 21. In addition, using the 0.45 ML/kg BW dose, ponies had another OST
performed directly off pasture. No differences were seen between the fasting and the nonfasting OST and authors concluded that performing the OST directly off pasture does not
affect the outcome of the OST 21. Increasing the dose of oral sugar improved the sensitivity
and repeatability of the OST to distinguish ponies with and without previous history of
laminitis. However, neither fasting duration nor increasing oral sugar doses has been

4

attempted in the horse. Due to differences in insulinemic and glycemic responses between
horses and ponies 25-27, further work is needed, specifically in the horse.

1.3

Seasonality of Insulin in Horses
The seasonal activity of the hypothalamic-pituitary adrenal-axis has been well

documented in the healthy horse 28-31. Insulin secretion has also been shown to vary with
season. Specifically, in the fall season in the healthy horse

32

and ponies predisposed to

laminitis 33, as well as in the spring 34,35, and summer in healthy horses 36. Seasonal insulin
fluctuations were attributed to changes in pasture nutrient content; specifically, nonstructural carbohydrates (NSC; starch + water-soluble carbohydrates, WSC). Furthermore,
seasonal changes in metabolic activity have also been seen in the healthy horse

37-39

. In

preparation for the winter season, horses promote fat storage, which was primarily done in
preparation for food shortage and migration prior to domestication 37. A primary function
of insulin is to induce fat storage

40

in mammals. In healthy geldings, an OGT was

performed across a year and insulin responses increased from June to December 37. Authors
proposed this was due to increased pancreatic β-cell sensitivity in preparation for winter 37.
Thus, seasonal metabolic and pasture nutrient changes to circulating insulin pose a
heightened threat for ID horses suffering from hyperinsulinemia.
Pasture nutrients inducing exaggerated insulin responses in ID horses during
specific seasons was first a theory by Frank and Tadros 6. This theory was confirmed when
ID ponies grazing pasture had higher insulinemic responses to supplemented WSC
compared to healthy ponies in the fall compared to winter

33

. Additionally, seasonal

fluctuations in basal insulins were seen in laminitic-prone ponies with higher plasma
5

insulin concentrations found in ponies in the summer compared to the winter, but other
seasons were not evaluated 36. However, another study found no seasonal changes in the
insulin responses to the OST in a group of 29 Finnhorses 41. Horses selected in this research
study were owned by the Natural Resource Institute and Ypaja Equine College and were
used for riding and driving. Horses were not metabolically categorized (ID or non-insulin
dysregulated; NID) prior to the study and it was found that 15 of the horses screened, at
least once, for ID based on post-OST insulin responses

41

. While this study did evaluate

seasonal insulin responses to the OST, it was done in only 1 breed and horses were not
managed similarly across the year. Furthermore, this study did not intentionally include
horses with ID; thus, insulinemic responses to the OST have not been evaluated seasonally
in the ID horse.

1.4

Management of Insulin Dysregulation in Horses
Due to ID horses having hyperinsulinemia, they are at an increased risk for HAL;

therefore, management of hyperinsulinemia and other factors associated with EMS are
crucial. There are three primary management tools for horses with ID – 1) pharmaceuticals,
2) weight loss 3) and nutrition. The two most common drugs used in ID horses are
metformin hydrochloride and levothyroxine sodium 7. These pharmaceuticals are often
used in extreme EMS cases or when ID horses are in an endocrinopathic laminitic (EL)
episode. Pain caused by EL often necessitates drug therapy due to the horse’s inability to
exercise and induce weight loss. Thus, these drugs are not prescribed for sole treatment of
ID or to replace the other forms of management (i.e., weight loss and nutrition).

6

In humans, exercise induced weight loss has been shown to reduce inflammation and
improve tissue insulin sensitivity

42,43

. The same has been seen in laminitic ponies

44

.

However, exercising intensities that are needed to induce weight loss in an ID horse are
often not achievable by owners 7. Only marginal improvements in insulin sensitivity were
seen when obese horses underwent light exercise
have shown improvements in insulin dynamics

45

46

. In addition, not all exercise studies

. Since not all ID horses are able to

exercise, due to laminitis, most recent recommendations for exercise are categorized based
on lamellar stability 7, with low to moderate exercise in horses without laminitis and lowintensity exercise in the previously laminitic horse. While weight loss induced by exercise
can be limited to only lamellar stable ID horses, dietary management is not.
Nutritional

recommendations

for

ID

horses

are

scarce,

recommendations originating from work done in NID horses

with
47,48

current

. Dietary

recommendations for ID horses focus on limiting NSC and its components, starch and
WSC, due to the ability of high concentrations of NSC to trigger EL 9,49. NSC consumption
triggers multiple pathways to stimulate insulin secretion.
First, facilitated diffusion of glucose and recruitment of additional glucose transporters
will stimulate insulin secretion

50

. Second, monosaccharides are sensed by sweet-taste

receptors 51, which are found on the tongue and in the L and K cells in the small intestine
52-54

. Sweet-taste receptor activation in mice and human analogs result in absorption of

glucose and stimulation of insulin secretion

55

. And finally, the incretin effect also

stimulates insulin secretion. Incretins are gastrointestinal hormones, specifically glucagonlike peptide-1 (GLP1) and glucose-dependent insulinotropic polypeptide (GIP),
responsible for amplification of insulin secretion after the ingestion of a carbohydrate meal
7

50

. In fact, 80% of glucose disposal can be attributed to the incretin effect 50. In additional

to the consumption of monosaccharides, the other component of NSC, starch also
stimulates insulin secretion, but the mechanisms are poorly understood

56

. Starch is

composed of both linear (amylose) and branched (amylopectin) glucose chains 57-59. Unlike
humans, equids do not produce much salivary amylase 59. Instead, equids rely on pancreatic
α-amylase to digest starch. A study completed in mice showed that feeding high starch
meals resulted in postprandial hyperinsulinemia compared to low starch meals

60

. While

starch did induce postprandial hyperinsulinemia in mice, it did not affect the glucose
response, which suggest that tissue IR is not affected by consumption of starch 56,60. With
both components of NSC triggering insulin secretion, limiting NSC in the diet of horses
with ID is crucial in the prevention of HAL.
The first study to suggest limiting NSC in the diet of ID horses was completed in the
polysaccharide storage myopathy horse (PSSM). In this study, healthy and PSSM horses
were fed 3 forage diets with 17%, 10% and 4% NSC on a DM basis. Significantly higher
insulinemic responses were seen for the forage diet with 17% NSC compared to 10% NSC.
Authors theorized that in other diseased models, like the insulin resistant (IR) horse,
decreasing NSC content within feedstuffs (<10% NSC) could also help manage these
horses 47. In healthy horses, Vervuert et al.

48

found that meals with > 1.1 g of starch/kg

BW resulted in higher insulinemic responses. This suggested the tolerable limit for starch
in healthy horses. Unfortunately, total NSC was not evaluated during that study, and it was
done in healthy horses. However, two nutritional studies have been conducted in the ID
animal. First, ID ponies were fed dry hay, soaked hay and haylage. ID ponies had lower
insulinemic and glycemic responses to soaked hay compared to dry hay and haylage, which
8

is most likely due to soaking leaching NSC from the hay 61. In ID horses, a high protein
meal, containing insulinotropic amino acids, produced postprandial hyperinsulinemia

62

.

Amino acids are known to stimulate insulin secretion 63, this was the first study in heathy
and ID horses demonstrating that dietary protein content should be taken into consideration
when formulating the diets of ID horses. While insulinemic responses to forage in ID
ponies and dietary protein in ID horses has been conducted, there is no research that focuses
on the insulinemic responses to NSC content in the diet for the ID horse. In the ID pony,
postprandial insulinemic responses to hydrolysable sugars has been found to be best
predictor of laminitis risk

13

. Thus, controlling the postprandial response, especially to

NSC, is of the utmost importance in the ID horse with hyperinsulinemia.

1.5

Overall Objectives and Specific Aims
The complexity of EMS and its phenotypes make it difficult to diagnose and manage

in equids. Most of the work conducted in the ID animal has been conducted in the pony,
which does not share the same glucose and insulin dynamics with the ID horse. Therefore,
we proposed to investigate the effects of season, the fed and fasted state, and dietary
nutrient content on insulinemic responses in the ID horse. To address this, 4 objectives
(OB) were examined.
(OB1) We determined if season affects insulin concentrations in ID horses. This objective
explored basal and post-OST serum insulin concentrations across all seasons in ID and
NID horses. In addition, we examined if body morphometrics and forage nutrients were a
driving factor of seasonal insulin concentrations.

9

(OB2) We explored if a higher dose of oral sugar would improve the diagnostic ability of
the OST in the ID horse.
(OB3) I addition to dose, we investigated if a short fast or collecting samples directly off
pasture from ID horses’ affects basal and post-OST insulins.
(OB4) Finally we investigated ID horses’ insulinemic responses to nutrient concentrations,
specifically NSC.
Aim 1: We determined if ID horses had similar insulinemic responses to NID
horses.
Aim 2: We determined if meal feeding triggered an insulinemic response in ID
horses.
Aim 3: We determined if a feedstuff with low NSC elicited a marked insulinemic
response in the ID horse.
Aim 4: We determined if there was a threshold for NSC in the ID horse.

10

Figure 1.1 EMS Phenotypes in the horse.
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Figure 1.2 Diagnosis of Insulin Dysregulation in the Equid.
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CHAPTER 2. SEASONAL INSULIN RESPONSES TO THE ORAL SUGAR TEST
IN HEALTHY AND INSULIN DYSREGULATED HORSES
2.1

Abstract
Seasonal effects on the response of horses to the oral sugar test (OST), used to

monitor insulin dysregulation (ID) status with the aim of reducing laminitis risk, are
unknown. Basal insulin (T0) and 60-minute (T60) OST (0.15ml/Kg BW karo-syrup light)
insulin responses were evaluated, once per each season over 2yrs, in ID (n=11 𝑥𝑥 = 14.9 +
4.3 yrs.) and non-insulin dysregulated (NID: n=11 𝑥𝑥 = 16.4 + 5.3 yrs.) horses housed at the
same farm. Seasonal morphometric measurements were collected: bodyweight (BW),

body-condition scores (BCS), and cresty neck scores (CNS). Paddock and supplemented
hay seasonal samples were collected and analyzed using wet chemistry analysis. Serum
insulin concentrations were measured by RIA. Data were analyzed via Minitab Software
20.2 with a mixed effects model with response variable of basal insulin, post-OST insulin,
and delta insulin (DI) ([post-OST]-[T0] = [DI]) and random factor of horse and fixed factor
of season, metabolic status, and paddock (area in which horses were contained over 2-year
period). Season had no effect on BW(p=0.99); however, BCS and CNS were higher in ID
vs NID in the spring, summer and fall (p<0.02). Paddock (p<0.05) but not hay (p>0.2)
analytes varied across season. ID horses consistently had higher T0, T60 serum insulin
concentrations vs. NID (p<0.02). Season had no effect on NID T0 serum insulins (p=0.31),
but T60 serum insulin concentrations were higher in the spring vs. summer (p=0.01). ID
horses’ T0 & T60 serum insulin concentrations were higher in spring than fall and summer
(p<0.05 & p<0.01) and winter T60 serum insulin concentrations were higher than fall
(p=0.04). ID horses changed their ID categorization across season, with T0 serum insulin
13

concentration confirming ID status only 21.1-63.6% of the time whilst T60 serum insulin
concentration confirmed 84.2-100% of the time. When diagnosing and monitoring ID,
season and individual horses’ environmental factors may need to be taken into
consideration.

2.2

Introduction
Equine Metabolic Syndrome (EMS), as defined by the European College of Equine

Internal Medicine (ECEIM) consensus statement 7, is a collection of risk factors for
endocrinopathic laminitis (EL). It has been suggested that EL should in fact be referred to
as hyperinsulinemia-associated laminitis (HAL) 8.The consistent feature of EMS and the
main risk factor for HAL is insulin dysregulation (ID). ID is a collective term that
encompasses basal and postprandial hyperinsulinemia, as well as tissue insulin resistance.
One or more components can be present in a horse with ID; and different tests are
recommended to evaluate these different ID components 7.
The frequently sampled IV glucose tolerance test (FSIGTT) and the euglycemic
hyperinsulinemic clamp are primarily used to evaluate tissue insulin resistance. These tests;
however, are costly and are not practical for routine use. The oral sugar test (OST) is a
practical test that can be performed easily in the field, and it has the advantage of assessing
the individual’s insulin response to the oral ingestion of hydrolysable carbohydrates (sugar
and starch) which may be linked with laminitis risk

12,13,16

. The Equine Endocrinology

Group (EEG) has suggested diagnostic cutoffs for basal insulin (depending on assay) of
<20 µIU/ML: non-insulin dysregulated (NID); 20-50 µIU/ML: equivocal (IDE); and >50
µIU/ML: ID and for post-OST insulins at 60-minutes (using 0.15 ML/kg BW karo syrup)
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of, >45 µIU/ML: ID 8. Relying exclusively on basal serum insulin concentrations; however,
can often result in a misdiagnosis 16 and our work has also recently shown that low basal
serum insulin concentrations do not exclude a diagnosis of ID; therefore, a dynamic test,
like the OST is recommended 64. While reference ranges for normal and ID horses’ basal
and post-OST insulins are available 8, no research has been conducted to determine if
season has any effect on these insulin responses especially in the ID horse.
Hypothalamic-pituitary-adrenal axis seasonal activity has been well documented
[5-8]. In addition, insulin concentrations have been shown in some studies to fluctuate
during specific seasons, including the fall 32,33, spring 34,35 and summer 36 in healthy horses.
Although, other studies have found no such seasonal variations in healthy horses, most
likely due to high variability in insulin responses 29,65. Place et al. (2010) for example found
no seasonal insulin fluctuations in healthy horses but speculated that ID/EMS horses would
most likely display seasonal insulin variation; however, no research was conducted to
support this statement. Any differences in insulin responses according to season have been
predominately linked to fluctuations in forage carbohydrates, due to season induced
changes in WSC, ethanol soluble carbohydrates (ESC) and starch contents in the forage
and possibly intake rates

34,66

. In addition, there are reported seasonal fluctuations in

metabolic activity especially in the summer and fall

37,39

. Changes in tissue insulin

sensitivity promote more fat storage in advance of the winter months to prepare for
migration or scarce food supply 37,39,67. In one year-long study plasma insulin responses to
the oral glucose test (OGT) were shown to increase from June to December in both healthy
geldings and pregnant mares, leading the authors to suggest that in preparation for winter,
pancreatic β-cell sensitivity is increased 37.
15

Seasonal serum insulin fluctuations have also been shown in the ID animal
response to the feeding of different carbohydrate sources

33

36

in

. In ponies with a history of

previous laminitic episodes, higher serum insulin concentrations were seen in the fall after
consuming glucose when grazing paddock compared to spring 33. Bailey et al. (2008) also
found seasonal serum insulin fluctuations in laminitic-prone ponies with their basal serum
insulins being higher in the summer compared to winter38. The researchers suggested in
this paper that seasonal changes in metabolic state may depend on the profile of nutrients
in paddock. Given that ID, compared to non-ID, horses may be even more predisposed to
HAL when given access to paddock or feeds with high WSC and/or starch contents,
repeated endocrine screening and monitoring of ID horses using the OST may be critical
in helping to reducing the risk of HAL. Therefore, the objective of the current study was
to evaluate the effect of season on basal and post-OST serum insulin concentrations over a
2-year period. In addition, morphometric body measurements of all horses and forage
nutrients were also examined to determine if these factors also changed with season and
therefore potentially influenced serum insulin concentrations and responses to the OST.

2.3
2.3.1

Methods & Materials
Animals & Housing

Horses resided on the University of Kentucky’s Department of Veterinary Science
farm as part of the special herd of metabolic research animals. Horses were selected based
on their previous endocrine history (2 prior OSTs with T60 serum insulin serum > 45
µIU/ML within 6-months prior to the study) and the initial OST of the study performed in
16

February 2017 (winter). All horses were considered free from pituitary pars intermedia
dysfunction (PPID) based on a non-fall basal ACTH (𝑥𝑥 = 25.09 +/- 14.51pg/ML)
<30pg/ML and no signs of hypertrichosis 8. Any horse that had clinical symptoms of PPID
was removed from the study to only include non-insulin dysregulated (NID) and ID horses.
Over the 2-year period all study horses remained free of PPID.
Based on the first OST the NID horses had basal (𝑥𝑥 = 16.17 + 5.68µIU/ML) and
T60 (𝑥𝑥 = 29.13 + 14.6 µIU/ML) serum insulin concentrations within the recommended 68
levels (i.e., basal < 20µIU/ML and < 45 µIU/ML for 60-minute post-OST insulin
concentrations). ID horses all had insulin concentrations 60-minute post-oral sugar
administration of > 45 µIU/ML (𝑥𝑥 = 125.5 + 46 µIU/ML)

68

. Their basal insulin

concentrations ranged from 19.02 µIU/ML to 69.2 µIU/ML, (𝑥𝑥 = 48.08 + 14.28 µIU/ML).
A total of 9 geldings and 13 mares were used, with 6 geldings and 5 mares in the ID
group (𝑥𝑥 = 14.9 + 4.3 years) and 3 geldings and 8 mares in the NID group (𝑥𝑥 = 16.4 + 5.3
years). The same 22 horses were used for both years of the study. The horses were of
mixed-breed and included Thoroughbred, Thoroughbred cross, Paint, Standardbred,
Standardbred cross, Morgan, Mustang, Tennessee Walking Horse, Warmblood, and
Kentucky Mountain horses. All horses were housed on the University of Kentucky’s C.
Oran Little research farm. The horses were separated across ten paddocks (e.g., pasture and
semi-dry lots), with both NID and ID horses being present in all paddocks. All study horses
remained in their same paddock for the duration of the study and had access to ad libitum
water, hay and a trace mineral/salt block throughout the 2 years of sampling. Both NID and
ID horses had access to the grass hay which was a mixture of timothy, fescue, and orchard
grass. Grass hay was harvested from University of Kentucky’s C. Oran Little research farm
17

and horses received three batches of this hay over the study. In addition, some of the NID
horses (n=3) received pure alfalfa hay ad libitum during the winter months. Forage
consumption was not monitored for each individual horse. The same NID horses that
received alfalfa hay during the winter (n=3) were also supplemented daily (year-round)
with a 50:50 mixture of whole oats (12.1% CP & 56.9% NSC on DM basis) and alfalfa
pellet (15.1% CP & 26% NSC on DM basis), to support weight maintenance; however, this
grain was not fed on sample collection days. All methods for the study were approved by
the institution animal care and use committee (IACUC; protocol #2014-1224).
2.3.2

Study Design & Sample Collection

An OST was performed for all study horses once per season across the 2 years,
starting with the winter of 2017 and ending in the fall of 2018: a total of 8 sampling points.
For 2017, samples were collected during the following months: February, April, August,
and October, whereas, in 2018, samples were collected in January, May, August, and
October. Seasons were defined based on the biannual solstices and equinoxes; with, the
winter season starting on December 21st, spring season starting on March 20th, summer
season starting on June 21st, and the fall equinox occurring on September 22nd. All 22
horses were sampled on the same day during each season in the morning hours (between
0800-1100) prior to any supplemental grain feeding but without fasting. Peripheral blood
was collected in 10 ml serum blood tubes (Covetrus) for basal samples (T0) via jugular
venipuncture before administration of oral sugar (0.15 ml/kg BW; Karo Light Corn Syrup)
and the post-oral sugar sample was collected at 60-minutes (T60). Within the same week
of sampling, all horses were assessed for their bodyweight via a calibrated portable scale
18

(model 700, Tru Test Inc.), body condition scores (BCS) 69, and cresty neck scores (CNS)
70

. BC and CN scores were taken by 3 trained personnel and the scores averaged. Seasonal

forage samples from the paddock and hay were also collected throughout the 2-year
sampling period and sent to Equi-Analytical (Dairy One Forage Laboratory, NY, USA) for
determination of nutrients via wet chemistry analysis. Hay bales from each season were
cored and analyzed. Representative samples of paddock forage were collected, when
sufficient forage was available for collection without soil contamination, from each
paddock for each season via sampling forage in a ‘W’ pattern in each paddock. Samples
from each paddock were analyzed individually. Forage samples were collected during the
same week that the OST was performed again during the morning hours. In addition,
paddock samples were also collected to determine the species of forage present by a trained
research analyst in forage and soil science at the University of Kentucky in the winter,
spring, and summer of 2018 via sampling forage in a ‘W’ pattern in each paddock. Rainfall
and temperature data for the month of sample collection for 2017 and 2018 were collected
from the University of Kentucky Ag Weather Center for the Lexington/Versailles area
overall.
2.3.3

Assays

After collection, blood samples were immediately centrifugated at 800g for 10
minutes, the serum and plasma aliquoted into 1.5 ml microcentrifuge tubes and frozen at 20 ̊ C. The serum was shipped on dry ice to Cornell University’s Animal Health Diagnostic
Center, for insulin analysis. Plasma collected on the first OST was analyzed for ACTH
concentrations via automated chemiluminescent enzyme immunoassay system (Immulite,
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Erlangen, Germany) 71. All serum samples were analyzed for insulin concentrations using
a commercially available human insulin radioimmunoassay (EMD, Millipore Corp,
Billerica, MA) and run-in duplicates

20

. The sensitivity of the assay, as reported by the

manufacturer is 2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation
were 7.4 and 6.3%, respectively. Horses with basal insulins >30µIU/ML, and/or 60-minute
post OST insulin concentrations >45 µIU/ML were considered ID according to the
guidelines at the time of the studies 68.
2.3.4

Statistics

Statistics were determined using Minitab Software 20.2 (Minitab LLC, PA, USA).
Prior to analysis, year 1 (2017) and year 2 (2018) were assessed for statistical differences
via mixed effect model and there was no difference between years (p=0.21). Therefore, to
strengthen analysis, response variables (BW, BCS, CNS, T0, T60 and delta insulin (DI))
and nutrients from paddock and hay were combined for each season. For example, winter
of 2017 response variables were combined with winter of 2018 response variables to only
have one ‘winter’. If data were not normal (i.e., did not meet assumptions of ANOVA) data
were log transformed, which resulted in normality. Mixed effects model were ran for BW,
BCS and CNS with a random factor of horse and fixed factors of metabolic status (ID and
NID), season (winter, spring, summer, and fall), and the interaction of metabolic
status*season. Similarly, insulinemic responses (T0, T60 and DI) were assessed with a
mixed effects model with random factor of horse and paddock, and fixed factors of
metabolic status, season, and the interaction of metabolic status*season. A general linear
model was run with factors of season and forage type (paddock or hay) and response
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variable of crude protein (CP), water-soluble carbohydrates (WSC), starch, and nonstructural carbohydrates (NSC) (all on a dry matter basis). If any differences were detected,
a Tukey post-hoc analysis was performed. Significance was determined at p<0.05 and a
trend was considered at 0.05< p<0.10.

2.4

Results
All horses remained clinically healthy during the study with no episodes of laminitis.

No animals showed signs consistent with PPID during the study requiring them to be
removed from the study. Samples from three horses were unable to be collected due to
issues unrelated to the study (abscesses and seasonal allergies) as described below. One
horse (ID) was not sampled in the either fall season due to being medicated for seasonal
allergies. The other two horses (1 NID and 1 ID) had foot abscesses and were on treatment
during sampling in the summer of 2018 and fall of 2018. Thus, winter and spring seasons
have 22 horses, summer has 21, and fall has 20 horses.
2.4.1

Morphometrics

Overall, there was no difference in BW between ID vs. NID horses (p=0.99);
however, BCS and CNS did differ (p<0.02), with ID horses having higher BCS and CNS
in the winter compared to NID in the spring, summer, and fall (Table 1). For all
morphometric measurements (BW, BCS, and CNS) there was no significant interaction
between season*metabolic status (p>0.3). There was no difference within ID or NID
animals across season for BW (p>0.3). NID horses BCS was highest in the winter
compared to summer and fall (p<0.01), but winter and spring did not differ (p=0.1).
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Similarly, NID horses CNS was highest in the winter compared to the summer and fall
(p<0.01), but winter and spring did not differ (p=0.11). ID horses BCS and CNS did not
vary across season (p>0.1).
2.4.2

Forage and Weather

In total, 50 paddock forage and 25 hay samples (across all 3 batches of hay) were
collected over the 2-year sample collection period. The specific differences in paddock
forage nutrient content across season are shown in Table 2. There was no change in the
mean CP, WSC, starch, or NSC content of the hay across season (p>0.2). Mean CP, WSC,
and NSC were; however, different across season for the paddock (p<0.02); although, starch
was not (p=0.2). WSC and NSC were highest in the spring which did not differ from
summer (p=0.8). Summer WSC and NSC was not different from winter (p=0.12) but was
different than fall (p=0.04). Winter WSC and NSC were not different from fall (p=1.0).
With respect to the changes in paddock grass type across the seasons: During the winter,
the species of paddock forage were 3.1 + 5.5% tall fescue, 8.4 + 3.2% Kentucky bluegrass,
0.6 + 0.7% orchard grass, 2.7 + 1.7% white clover, 43 + 17.3% weeds, and 42.7 + 23.6%
bare soil; whereas spring had the following species composition: 5.7 + 4.1% tall fescue,
5.9 + 5.2% Kentucky bluegrass, 7.8 + 6.4% orchard grass, 14 + 5.4% white clover, 15.9 +
9.7% weeds, 48.2 + 20.3% bare soil, and 3.3 + 7.1% nimble will, and summer paddock
forage was composed of the following: 7 + 8.5% tall fescue, 7.5 + 4.9% Kentucky
bluegrass, 10 + 14.1% orchard grass, 13 + 1.4% white clover, 17.5 + 0.7% weeds, 41.5 +
27.6% bare soil, and 4.5 + 2.1% nimble will. Thus, throughout the year paddocks were
predominately composed of weeds (25.5%) and bare soil (44.1%) with tall fescue,
22

Kentucky bluegrass, orchard grass and white clover (30%) making up the rest of the
paddocks.
For the winter collections average temperature for the months of collection were
6.2 ̊ C (February 2017) and 4.1 ̊ C (January 2018) and rainfall was 23 cm (February 2017)
and 11.1 cm (January 2018). Spring monthly average temperatures were 9.9 ̊ C (April
2017) and 17.8 ̊ C (May 2018) and average rainfall was 11.4 cm (April 2017) and 15.6 cm
(May 2018). Summer monthly average temperatures were 24.2 ̊ C (August 2017) and 22.4 ̊
C (August 2018) and average rainfall was 16.7 cm (August 2017) and 9.3 cm (August
2018). Finally, fall monthly average temperatures were 14.6 ̊ C (October 2017) and 14.8 ̊
C (October 2018) and average rainfall was 7.6 cm (October 2017) and 13.3 cm (October
2018).
2.4.3

Insulin Responses

Paddock was not statistically significant for any response variable (T0, T60 or DI)
(p>0.4). As expected, NID and ID horses’ T0, T60 and DI were different at each time point
(p<0.02). NID horses T0 insulin concentrations, did not vary with season (p=0.34);
however, ID horses had higher basal insulin concentrations in the spring compared to fall
(p<0.01) and summer (p=0.05), but they were not different from the winter (p=0.7). NID
horses; had higher T60 insulin concentrations in spring compared to the summer (p=0.01).
ID horses T60 serum insulin concentrations were greater in the spring compared to the fall
(p<0.01) and summer (p=0.01); and in the winter they had higher insulinemic responses
compared to the fall (p=0.04). Delta insulin responses did not vary in ID horses with season
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(p>0.67); however, the NID horses DI responses were greater in the spring compared to
the summer (p=0.02).
Although all ID horses had positive OSTs prior to the study and their first OST
confirmed this metabolic status; when examining on an individual animal basis (n=22 per
season; 11 ID horses x 2 seasons) the results (T0 and T60) of each OST, ID categorization
did not remain constant across the study and seemed to fluctuate through the year and with
season. These changes in apparent ID status are illustrated in Table 3 where on the basis of
the basal insulin at each time point each original ID horse was re-categorized as being ID
(>50 µIU/ML), ID equivocal (IDE; 20-50 µIU/ML), or NID (< 20 µIU/ML). They were
also re-categorized using their post-OST (T60) insulin concentrations as being ID (T60 >
45 µIU/ML) or NID (T60 < 45 µIU/ML).

2.5

Discussion
To the authors’ knowledge, this is the first study to evaluate basal and post-OST

insulins in ID and NID horses over all 4 seasons. The results suggest that ID and NID
horses do have differences in their insulin responses according to the season. Since the
management practices remained constant across the 2-year sampling period differences in
insulin concentrations could be attributed to one or more of the following: changes in
adiposity, metabolism, forage nutrients as well as other factors. Importantly, some animals
that had been categorized originally as ID would have been recategorized as NID or IDE
throughout the study, where basal insulin concentrations would diagnose ID horses 56%
and 42% as IDE and ID, respectively. Whereas post-OST insulin concentrations would
have diagnosed ID horses as 3% and 94% as IDE and ID, respectively.
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Based on morphometric measurements BW did not change throughout the sampling
period for NID or ID horses and this most likely reflects management practices on the farm.
Przewalski horses living in a natural un-managed environment undergo seasonal changes
in BW, with peaks in the fall and lows in the spring due to seasonal availability and quality
of forage

39

. In comparison, a study conducted in young Thoroughbred racehorses in a

highly managed environment, male horses had the highest weights in fall and winter and
the lowest in the summer. Whereas mares had the highest weights in the fall and lowest in
the spring

72

. Researchers controlled for Thoroughbred growth in statistical analysis

revealing that horses maintain a seasonal energy balance and changes seen were not due to
growth, but to season. In the current study, all horses were managed to maintain their
weight by the provision of ad libitum grass forage plus some NID horses received
additional nutritive forage and energy providing complementary feeds as described earlier;
therefore, lack of fluctuations in weight are not surprising. Interestingly the ID horses did
not change their BCS or CNS throughout the 2-year period; however, the highest scores
for the NID horses were reported in the winter compared to summer and fall, but not spring.
Seasonal changes in BCS 73 and CNS 74 have been reported, with higher scores also being
reported in the winter with lower scores in the fall. Season has been shown to influence fat
deposition with the greatest increase in the fall 75. Like other species, adipose tissue in the
horse acts as an endocrine organ secreting pro-inflammatory cytokines such as TNFα and
IL6 and adipokines like leptin and adiponectin that may increase and decrease with fat
mass accumulation

76,77

. Higher concentrations of several pro-inflammatory cytokines

(IL6, TNFα, IL4, etc.) have been shown in: EMS pony serum and adipose tissue 77, adipose
tissue in insulin resistant horse

78

, plasma of previously laminitic ponies
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79

, and in the

plasma, adipose tissue, and skeletal muscle in horses with induced acute hyperinsulinemia
80

. Furthermore, hyperinsulinemia induces adipose accumulation, which has been

associated with higher leptin concentrations in ponies 81, and adiponectin concentration has
a negative correlation with insulin as well as BCS 19. Animals during a weight loss study
carried out in the winter actually showed an increase in subcutaneous fat in some areas
suggesting mobilization to facilitate insulation

82

. Thus, in the current study, the

fluctuations in BCS, but not in BW, in the NID animals may reflect changes in body
composition (and % body fat) due to seasonal/environmental changes as well as energy
balance. In contrast, ID horses lack of fluctuation in BCS and CNS could be due to
constant/regular hyperinsulinemia, resulting in either increased fat deposition or
retention/preservation of regional or visceral adipose tissue. When fed a similar diet over
a 12-week period ponies with an obese BCS had half the appetite and did not change BW
or BCS compared to thin or moderate BCS ponies 83. This suggests that there is an unknown
driver for obese animals to stay obese or perhaps new classifications or refinements need
to be set for obese horses 83. Whether this lack of fluctuation is a consistent finding in ID
animals needs to be confirmed and it would be valuable to measure key cytokines and
adipokines in future studies.
Both ID and NID horses had higher T60 concentrations in the spring than in the summer
and the NID animals’ delta insulin responses were also higher in the spring that the
summer. This could just reflect a response to increased WSC content of the paddock
pasture in the spring as has been suggested in laminitic 36 ponies as well as healthy animals
32,34,35,37

and/or an underlying circadian biological effect. Certainly, in the current study,

spring had the highest numerical NSC, WSC, and CP concentrations in the paddock pasture
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which could potentially explain these results, but the NSC was not significantly different
from that found in the winter or summer. Forage NSC in the winter (7.3 + 0.9%) and fall
(7.7 + 3.6%) were the same but basal insulin concentrations in the ID horses were higher
in the spring compared to fall; furthermore, T60 responses were higher in the winter
compared to the fall. Also, paddocks were composed of 3 pastures and the remaining were
semi—dry lots. Thus, forage nutrient content may not explain all the findings. It may be
that during the winter the ID animals preferentially grazed on any high NSC plants that
were present or alternatively an underlying circadian effect could simultaneously be
influencing ID horses’ insulin concentrations. Further work needs to be conducted to
elucidate any biological shift that might occur in ID horses and how that interacts with
paddock nutrients. In addition, a limitation of this study when trying to link changes in
paddock pasture nutrients with changes in metabolic responses is that paddock samples
were only collected on one occasion at each season and at one time point. It is not possible
to say exactly what forage nutrients were in the weeks/days preceding blood sampling
although it is known that variation across the day and from day to day and even within a
paddock can occur 59. Although, this was not the purpose of this study, we did carry out an
all-day forage sample collection after the study concluded in the month of August. Two
paddocks (SP1 & SP2) were selected where horses were housed during the study and
forage samples were taken at 0700, 1100, 1500, and 1900 hours. Minimal nutrient variation
was seen throughout the day on this occasion for CP (10.8-13.1% SP1 and 10-12% SP2),
starch (4.8-7.4% SP1 and 5-7.5% SP2), WSC (10.4-11.4% SP1 and 10.5-12.3% SP2), and
NSC (15.8%-18.8 SP1 and 16.1-19.2% SP2). In future studies such an evaluation might be
of value at least on the day before blood sampling.
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In the current study, ID horses’ T0 and T60 insulin did not differ between winter and
spring. However, ID horses’ serum insulin in the fall were the lowest compared to the
winter and spring. This suggests that pancreatic β-cell sensitivity was not increased leading
into the winter in ID horses in the current study 37. This could be due to chronic basal and
postprandial hyperinsulinemia in ID horses affecting the sensitivity of the pancreatic βcells to insulin, which was confirmed by Lindase et al.
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who found a hyperbolic

relationship between β-cell response and insulin sensitivity. Thus, in NID horses, it is likely
that they do undergo a metabolic shift, but ID horses the metabolic shift leading into the
winter is disrupted by abnormal insulin sensitivity. In addition, during colder temperatures,
horses will decrease foraging and movement to conserve energy needed to maintain
appropriate body temperature

85

. Therefore, horses are burning internal energy sources,

such as glycogen, releasing pancreatic glucagon to access free glucose. Horses rarely have
abnormal circulating glucose concentrations, unless they have diabetes mellitus

86

.

Euglycemia is also seen in hibernating bears, which is most likely due to hyperinsulinemia
and hyperglucagonemia

87

. Insulin induces anti-lipolysis indicating that horses are not

breaking down adipose tissue for energy, but are instead storing more fat, which is
consistent with the hyperinsulinemic state 88. Glucagon was not measured but should be
considered in future studies to elucidate if ID horses experience hyperglucagonemia in the
winter season.
Both basal hyperinsulinemia as well as normal basal insulin levels were seen in the
ID horses (categorized as ID based on 2 previous OSTs and the initial OST), throughout
the 2-year sampling period. It is known that not all ID horses have resting hyperinsulinemia
14,17,18,89

; therefore, perhaps such changes are not unexpected. Certainly, our recent study
28

has suggested that an ID horses’ metabolic status can change over a relatively short period,
especially if basal serum insulin concentrations are used

64

. This previous study showed

that over a 6-week period, 8 out of the 12 horses evaluated had a categorical shift in ID
status (67%) based on basal serum insulin concentrations alone. Whereas using the postOST insulins only 2 out of 12 horses changed their ID categorization from ID to NID,
confirming the value of using a dynamic test such as OST. Changes in categorization could
reflect the poor repeatability of the OST as a diagnostic test, which could be due to interassay variation, intra-assay variation, individual response variation, and environmental
factors 12,19,23,24. It has been suggested that for determining ID or NID, the reliability of the
OST is acceptable 17 and therefore any change in ID status could reflect a true metabolic
shift. In the current study, ID horses categorization shifted from ID to IDE (n=6), IDE to
ID (n=4), and NID to ID (n=1) based on serum basal insulin; whereas, categorization
shifted from ID to IDE (n=2) only based on post-OST serum insulin concentration. In this
previous study carried out over a 6-week period, a change of season (winter to spring) did
occur, which could have been one of the drivers for the changes. Certainly, Borer et al.
found that previously laminitic ponies had higher insulin concentrations after consumption
of glucose while grazing from a paddock in the fall compared to spring33. Interestingly, in
the current study, fall had the greatest percentage of ID horses categorized as IDE
categorization on the basis of both T0 (73.7%) and T60 (10.5%) concentrations. Also, fall
had the lowest percentage of IDs retaining their ID categorization based on their T0
(21.1%) and T60 (84.2%) concentrations in comparison to all other seasons. Borer et al.
found increased variability post consumption of WSC in the fall for insulin
concentrations33. This requires further evaluation but the result from this study confirms
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that changes in ID categorization can occur. The data also suggests that categorization
might be influenced by the time of year and that perhaps interpretation of ID status based
on current cut off values following an OST during the fall season should be done with
caution.
Over the 2-year sampling period, no incidence of HAL was observed in any NID
or ID horse. No subjective lameness score (obel) or clinical lameness examination were
recorded for the study purposes. It is important to note that the horses in this study were
maintained primarily on semi-dry lots therefore, limiting the ability of grass to induce
HAL. A suggested laminitic threshold for insulin is 200 µIU/ML 90. In the current study,
basal and post-OST serum insulin concetrations were >150 µIU/ML on 5.7% and 17% of
occasions respectively and >200 µIU/ML on 4.5% and 9.1% respectively in the ID horses.
Studies have reported the rate of recurrence for EL of around 34%

67,91

. De Laat et al.

(2019) found a significant relationship between season and the recurrence of laminitis, with
summer and fall having higher rates than spring67. Interestingly, no HAL was observed
during the study even though insulin concentrations were close to or exceeded the laminitic
threshold for some ID horses. The difference between the current study and the study that
suggested a laminitic threshold was the fact that this study included naturally occurring ID
horses exposed to intermittent (grazing paddock) and the previous study used a model to
induce hyperinsulinemia via euglycemia, hyperinsulinemic clamp

90

. ID manifests

differently in individual horses and each should be managed accordingly. Thus, authors
suggest monitoring basal and post-dynamic OST insulin concentrations regularly
throughout the year to identify times that may pose an increased risk for HAL for each
individual horse.
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2.6

Conclusion
This study found that season does affect serum insulin responses in ID horses, with

the highest responses to the OST in the spring and winter especially compared to the fall.
High insulin serum concentrations in the spring and winter could be the result of ingestion
of oral hydrolysable carbohydrates or a metabolic shift. In addition, veterinarians and
researchers should be cautious when diagnosing horses with ID based on basal insulin
alone. Furthermore, seasonal fluctuations in insulin should be considered when evaluating
a horse for ID in season associated with lower serum insulin concentrations (i.e. summer
or fall), as that may not be representative for all seasons based on the current study.

31

Table 2.1. Descriptive Statistics for Morphometric Data.
Data displayed as mean + standard deviation (median) for Non-Insulin Dysregulated (NID)
and Insulin Dysregulated Horses (ID).
NID Horses

ID Horses

Winter

579.7 + 74.7 (562.5) Aa

583.6 + 87.4 (572.2) Aa

Spring

568.0 + 72.1 (552.0) Aa

570.9 + 86.3 (557.9) Aa

Summer

575.4 + 69.9 (559.7) Aa

569.9 + 82.7 (554.7) Aa

Fall

575.8 + 68.1 (556.6) Aa

576.9 + 87.4 (555.7) Aa

Winter

5.7 + 0.6 (5.8) Abab

6.3 + 1.0 (6.4) Aa

Spring

5.4 + 0.7 (5.5) Bca

6.0 + 0.7 (5.9) ABCa

Summer

5.3 + 0.6 (5.4) Cb

6.1 + 0.6 (6.0) ABCa

Fall

5.2 + 0.5 (5.2) Cb

6.1 + 0.9 (5.8) ABCa

Winter

1.7 + 0.6 (1.6) Aba

2.6 + 0.9 (2.5) Aa

Spring

1.2 + 0.7 (0.9) Ca

2.1 + 1.0 (1.9) Aba

Summer

1.3 + 0.5 (1.1) Ca

2.4 + 0.9 (2.3) Aba

Fall

1.5 + 0.5 (1.3) Bca

2.4 + 1.0 (2.0) Aba

Bodyweight (kg)

Body Condition
(BCS)

Scores

Cresty Neck Scores (CNS)

Differences between rows (between metabolic groups) are indicated by uppercase superscripts
for each morphometric measurement.
A, B, C

Differences within columns (between seasons within metabolic groups) are indicated by
lowercase superscripts for each morphometric measurement.
a, b, c
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Table 2.2. Nutrients from Forage.
Values presented as mean + standard deviation. Quantity of samples from paddock in each
season are as follows: winter n=7, spring n=10, summer n=19, and fall n=14. Quantity of
samples from hay in each season are as follows: winter n=8, spring n=8, summer n=5, and
fall n=4.
Paddock Samples

Hay

Winter

19.2 + 8.5 B

16.2 + 4.1 a

Spring

28.2 + 3.8 A

16.1 + 2.8 a

Summer

17.8 + 3.2 B

12.7 + 4.1 a

Fall

14.6 + 5.3 B

10.5 + 2.9 a

Winter

5.5 + 1.6 BC

6.0 + 2.0 a

Spring

10.2 + 4.2 A

6.1 + 1.9 a

Summer

8.9 + 3.7 AB

6.0 + 1.1 a

Fall

5.6 + 2.8 C

7.9 + 1.2 a

Winter

1.8 + 1.5 A

1.1 + 0.4 a

Spring

2.2 + 3.2 A

1.0 + 0.5 a

Summer

1.0 + 0.9 A

0.8 + 0.3 a

Fall

2.0 + 1.4 A

1.0 + 0.2 a

Winter

7.3 + 0.9 AB

7.1 + 1.8 a

Spring

12.4 + 5.3 A

7.1 + 1.9 a

Summer

9.9 + 3.9 AB

6.8 + 1.2 a

Fall

7.7 + 3.6 B

8.9 + 1.2 a

CP (% DM)

WSC (% DM)

Starch (% DM)

NSC (% DM)

A, B, C

Differences between paddock are indicated by uppercase superscripts for each
measurement.
a

Differences within hay are indicated by lowercase superscripts for each measurement.

Abbreviations: Crude protein (CP), Water-soluble carbohydrates (WSC), Non-structural
carbohydrates (NSC), Dry Matter % (% DM).
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Table 2.3. ID Horses Change in Metabolic Status Across Season.
Categorization of ID horses across season based on EEG’s (2020) cutoff values for the OST (0.15ML/kg BW dose). Each ID horse is
represented twice because they were twice in each season (2017 and 2018).
Basal

Post-OST

Winter

Spring

Summer

Fall*

Winter

Spring

Summer

Fall*

% NID

4.5
(1/22)

0

0

5.3

4.5

0

4.5

5.3

(0/22)

(0/22)

(1/19)

(1/22)

(0/22)

(1/22)

(1/19)

% Equivocal

45.5
(10/22)

36.4

73.7
(14/19)

0

0

(8/22)

68.2
(15/22)

(0/22)

(0/22)

0
(0/22)

10.5
(2/19)

% ID

50
(11/22)

63.6
(14/22)

31.8
(7/22)

21.1
(4/19)

95.5
(21/22)

100
(22/22)

95.5
(21/22)

84.2
(16/19)

Abbreviations: Equine Endocrine Group (EEG), Percentage of horses diagnosed non-insulin (%NID), Percentage of horses diagnosed
as equivocal (% Equivocal), Percentage of horses diagnosed as insulin-dysregulated (%ID), Post-oral sugar test (Post-OST).
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Figure 2.1. Basal Insulin Concentrations for ID and NID Horses Across Season.
Significant difference is indicated by difference in letter within each metabolic group and
between metabolic group with the * symbol.
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Figure 2.2. Post-Oral Sugar Insulin Concentrations for ID and NID Horses Across
Seasons.
Significant difference is indicated by difference in letter within each metabolic group and
between metabolic group with the * symbol.
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Figure 2.3. Delta Insulin Values for ID and NID Horses Across Seasons.
Significant difference is indicated by difference in letter within each metabolic group and
between metabolic group with the * symbol.
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CHAPTER 3.

EFFECT OF DOSE AND FASTING ON ORAL SUGAR TEST
RESPONSES IN INSULIN DYSREGULATED HORSES

Journal of Equine Veterinary Science, 2021;107:103770.
doi.org/10.1016/j.jevs.2021.103770

3.1

Abstract
The oral sugar test (OST) is frequently used to identify insulin dysregulated (ID)

equines. The effect of fasting and varying sugar dose for the OST has been investigated in
the pony but little work has been done in the horse. This study aimed to investigate 1) an
OST response with access to forage continued until the time of the OST or prevented for 3
hours prior to the OST and 2) responses of ID and non-insulin dysregulated (NID) horses
to 2 different OST doses. Twenty-one mixed-breed horses (14.8 + 3.2 years; 574.3 + 83.3
kg) were used in two randomized crossover studies. Seven ID and 7 NID horses were used
in study A, and 8 ID and 8 NID in study B. Study A horses underwent an OST (0.15 ML/kg
BW) either after a fast (FA) or directly off pasture (FE). Study B horses received either a
low (LD; 0.15 ML/kg BW) or high dose (HD; 0.45 ML/kg BW) OST on one occasion each.
Blood was collected at basal (T0), and post-60 minute (T60) for later determination of
insulin (RIA). Data were analyzed via ANOVA with repeated measures. ID horses had
significantly (p<0.05) greater insulin responses than NID for all OSTs. There was no
statistical difference between LD vs. HD mean insulin concentrations (T0, T60, delta
insulin) for either ID or NID horses. ID had higher T0 (p<0.01) for FE compared to FA;
however, FE and FA did not significantly affect T60 or delta insulins (DI) concentrations.
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3.2

Introduction
Insulin dysregulation (ID) is the main consistent component of the equine metabolic

syndrome (EMS)7 and is the collective term for tissue insulin resistance, basal and
postprandial hyperinsulinemia. The response to oral hydrolysable carbohydrates is thought
to be linked with the level of laminitis risk13 and being able to practically identify and
monitor animals with ID is considered important7. The oral sugar test (OST) is a clinically
recognized and recommended diagnostic test that examines the glucose-induced insulin
response to oral nonstructural carbohydrates (NSC)12. The OST originally reported by
Schuver et al. (2014) represents the metabolic response to ingested carbohydrates by
stimulating the enteroinsular axis, which includes the incretin effect and activation of the
sweet taste receptors5,9,12,92.
Since the original report12 there have been suggested refinements to the protocol,
for example in ponies a higher oral sugar dose (0.45 ML/kg BW vs. the original 0.15 ML/kg
BW of Karo Light Corn Syrup; AHC Food Companies INC.) was shown to be better able
to differentiate between non-laminitic and previously-laminitic ponies21 and currently it is
recommended that, whilst the 0.15 ML/kg BW dose should be used routinely, the 0.45
ML/kg BW dose may be of value in equivocal cases8. Two studies have used 0.45 ML/kg
BW oral sugar dose for the OST in horses16,21, but there have not been any reports
comparing the results of the original and this higher dose. Researchers, however, did find
that the OST (0.45 ML/kg BW) was able to identify more ID-positive equids compared to
basal insulin alone16,93.
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It has been recommended that, prior to the OST, horses should not receive grain or
other high NSC feeds due to effects on basal, as well as post-oral sugar insulin responses12.
When healthy non-insulin dysregulated (NID) horses had free choice mixed grass hay prior
to the OST there was little effect of oral sugar administration and a significant increase in
insulin was only seen following a 3, 6, and 12-hour fast11. In ponies evaluated either post
a fast or straight from being on pasture with hay17 fasting also resulted in higher insulinemic
concentrations compared to the testing from pasture. However, the authors suggested that
either the pasture fed or fasted results in fact could be used to differentiate animals
providing specific cut-off points were used for each methodology. Given potential
differences in insulin and glucose dynamics between ponies and horses25-27, it is important
to evaluate further the influence of OST testing either from pasture or after a short fast in
the horse.
Two studies were therefore conducted in horses that had previously been identified
as being either NID or ID. The first evaluated the effect of short-term fasting on OST
insulin responses. The second evaluated the effect of varying the dose of the oral sugar. It
was hypothesized that a higher dose of oral sugar would better differentiate ID horses by
improving the diagnostic ability of the test, and that fasting would increase insulinemic
responses to the OST.

3.3

Methods & Materials

Studies were carried out between August 2018 – August 2019.
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3.3.1

Animals

Overall, 21 adult horses (mean + SD: 14.8 + 3.2 years and 574.3 + 83.3 kg) of mixed
breeds, including Thoroughbred (n=6), Appaloosa (n=1), Paint (n=1), Thoroughbred cross
(n=3), Tennessee Walking Horse (n=1), Warmblood (n=1), Standardbred cross (n=1),
Rocky Mountain Horse (n=1), Percheron x Thoroughbred Cross (n=1), Quarter Horse
(n=1), and unknown mix breed (n=6) were used. The horse demographics for each study
are described in Table 1. One-week prior to the study, body condition (1-9; BCS) and cresty
neck score (0-5; CNS) were determined for each horse by 3 trained personnel and the
average recorded69,70. In addition, bodyweight (BW) was measured with a calibrated
portable agriculture scale (model 700, Tru Test Inc, Mineral Wells, TX). All horses were
considered to be non-PPID (i.e. no signs of hypertrichosis and non-fall basal ACTHs
(chemiluminescence immunoassay [Immulite® 1000]71) below the recommended cutoff of
< 30pg/ML8. Horses were categorized into metabolic groups (NID and ID) by their
previous medical history. This included basal insulins and 60-minute post (T60) OST
insulin responses in different seasons over the previous 6 months in order to account for
seasonal changes in insulinemic responses, thereby enabling improved accuracy of the ID
diagnosis. Criteria to be included in the ID metabolic group were at least 2 basal insulins
> 30 ΜIU/ML and T60 insulin > 45 ΜIU/ML based on the recommendations at the time
of the study20. Study A used 7 horses with ID and 7 NID; whereas study B used 8 ID and
8 NID; nine horses (4 ID and 5 NID) were used in both study A and B. The remaining 8
horses that changed from study A to B were due to various unrelated issues. Horses were
group housed in 4-acre semi-dry lots (minimal grass and weeds) and had access to ad
libitum grass hay when not being sampled. All procedures for the study followed the US
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National Research Council’s Guide for Care and Use of Laboratory Animals and had
approval (#2018-2937).
3.3.2

Study Design

For both studies, horses were brought into 3.7 x 3.7 m individual pens (to which
they were acclimatized) when being sampled, where they had access to water, but no forage
or grain. Blood samples were collected into 10 ML serum vacutainer blood tubes, put in a
37 ̊ C water bath for coagulation prior to centrifugation, and processed within 1 – 2 hours
after collection by centrifugation at 800 g x 10 minutes with the serum being aliquoted and
frozen (-20 ̊ C) for later determination of insulin concentrations as described below.
Samples were kept at -20 ̊ C for 1-week prior to being shipped on dry ice to Cornell
University’s AHDC Endocrinology Laboratory.
3.3.2.1 Study A

All 14 horses underwent an OST either directly off pasture (FE) or following a 3hour fast (FA) on two separate days, separated by a week21. Horses were randomly assigned
to the two treatments, so that both treatment (FE and FA) and metabolic groups (NID and
ID) were evenly represented on each testing day. At 0800, horses that were assigned to FA
treatment were brought into their pen. Horses that were assigned the FE treatment remained
in the paddock where they had access to limited pasture and ad libitum grass hay. At 11.00,
the FE treatment group were brought into individual pens. Within a 30-minute period both
treatment groups (FE and FA) had a basal blood sample (T0) collected so that both
treatment groups had basal blood collected between 11.00 -11.30am, followed by the
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immediate administration of 0.15 ML/kg BW Karo Light Corn Syrup via a 60 ML cathetertipped syringe. Sixty-minutes following the oral administration of oral sugar, a T60 sample
was taken. All oral sugar doses had 5 ML of sugar added to account of accidental spillage.
3.3.2.2 Study B

All 16 horses received two doses of Karo Light Corn Syrup either 0.15 ML/kg BW
(LD) or 0.45 ML/kg BW (HD) on 2 separate days, separated by a week. Prior to both
studies, horses were housed on semi-dry lots with access to grass hay ad libitum. Horses
from each metabolic group were randomly assigned to either LD or HD on day 1 or 2. Both
dose and metabolic group were evenly represented for each day of testing. In the morning
hours (0700-0800), all horses were brought into separate pens and had a T0 sample.
Immediately following, either the LD or HD was given to each horse with 60 ML cathetertipped syringes. All oral sugar doses had 5 ML added for accidental spillage when dosing.
3.3.2.3 Assays

Serum insulin was analyzed by Cornell University’s Animal Health and Diagnostic
Centre endocrinology laboratory via human insulin radioimmunoassay (RIA) (EMD
Millipore Corp, Billerica, MA) and run-in duplicates [20]. The sensitivity of the assay, as
reported by the manufacturer is 2.72 µIU/ML. The mean intra- and inter-assay coefficients
of variation, determined by Cornell University, were 7.4 and 6.3%, respectively. Horses
with basal insulins >30 µIU/ML, and/or 60-minute post OST insulin concentrations >45
µIU/ML were considered ID according to the guidelines at the time of the studies [19].
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3.3.3

Statistics

Statistics were run on Minitab Software 20.2 (Minitab LLC, PA, USA). All
statistical models were assessed for normal homoscedasticity and residuals. Study A used
a mixed effects model with all insulinemic concentrations (T0, T60, delta insulin (DI; [T60
insulin] – [T0 insulin]) with fixed factors of metabolic status (ID, NID) and treatment (FA,
FE), random factor of horse, and covariate of day of sampling (D1, D2). Interactions were
also assessed, which included day*treatment and metabolic status*treatment. Similarly,
study B’s mixed effects model included all insulinemic concentrations with fixed factors
of metabolic status (ID & NID) and treatment (HD & LD), random factor of horse, and a
covariate of day of sampling (D1 & D2). Like study A, interactions were also assessed for
study B. Tukey post-hoc analyses were performed to assess any comparisons. T-tests were
performed to evaluate differences in age, BW, BCS, and CNS [21]. Statistical significance
was considered at p<0.05.

3.4
3.4.1

Results
Study A

There was no difference in age (p=0.14) or BW (p=0.50) between ID vs. NID
horses; however, BCS (p=0.01) and CNS (p<0.01) were different between the metabolic
groups (ID and NID) (Table 1 & Table 2). There was a statistical difference between ID
vs. NID horses for basal insulin; (p<0.01) and metabolic group*treatment (p=0.03).
However, there were no differences in basal insulin concentrations for sampling period
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(p=0.87), treatment (p=0.18), or day*treatment (p=0.58). Post-hoc analysis indicated that
ID-FE had higher basal insulin concentrations than ID-FA (p<0.01; Figure 1); however,
NID-FE and NID-FA were not different (p=0.99). Interestingly, ID-FA and NID-FA basal
insulin concentrations were not different (p=0.64); however, ID-FE and NID-FE basal
insulins were (p<0.01). Post-oral sugar insulin responses (T60) were different between
metabolic groups (NID vs. ID; p<0.01); however, there were no differences in sampling
period (D1 vs. D2; p=0.59), treatment (p=0.34), sampling period*treatment (p=0.73), or
metabolic group*treatment (p=0.06). Post-hoc analysis for T60 indicated that there was a
difference in ID-FE vs. ID-FA (p=0.04), ID-FA vs. NID-FA (p=0.02), and ID-FE vs. IDFA (p<0.01); however, no difference was found for NID-FE vs. NID-FA (p=1.00). Finally,
DI was different between metabolic groups (NID vs. ID; p<0.01); however, no other
differences were found for any other fixed or random factor. Post-hoc analysis revealed
that NID-FA vs. ID-FA (p<0.01) and NID-FE vs. ID-FE (p<0.01) were different; however,
no other differences were found.
3.4.2

Study B

Again, there was no difference in age (p=0.55) or bodyweight (BW; p=0.17) for ID
and NID horses; however, BCS and CNS was different, p<0.01 (Table 1 & Table 2). Basal
insulin concentrations (T0) were different between ID vs. NID horses (p<0.01); however,
sampling period (D1 vs. D2; p=0.17), treatment (HD vs. LD; p=0.11), sampling
period*treatment (p=0.17), and metabolic group*treatment (p=0.13) were not different.
Post-hoc analysis for T0 confirmed that ID-LD vs. NID-LD was different (p=0.01);
however, ID-HD were not different from NID-HD (p=0.25). Similar results were found for
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post-oral sugar responses (T60) where ID vs. NID horses were different (p<0.01); however,
no other differences were found in the model for sampling period (D1 vs. D2; p=0.34),
treatment (HD vs. LD; p=0.25), sampling period*treatment (p=0.19), or metabolic
group*treatment (p=0.64). Post-hoc analysis for T60 showed that ID-HD vs. NID-HD
(p=0.02) and ID-LD vs. NID-LD (p=0.03) were different from each other, but NID-LD vs.
NID-HD (p=1.00) and ID-LD vs. ID-HD (p=0.94) were not different from each other.
Finally, DI responses were different between NID vs. ID horses (p=0.01); however, no
other differences were found for sampling period (D1 vs. D2; p=0.44), treatment (LD vs.
HD; p=0.65), sampling period*treatment (p=0.39), or metabolic group*treatment (p=0.12).
Post-hoc analysis for DI responses showed no differences for NID-LD vs. NID-HD
(p=0.98), ID-LD vs. ID-HD (p=0.25), or ID-LD vs. NID-LD (p=0.08), but NID-HD and
ID-HD were different (p=0.01).
Interestingly, two of the 8 animals previously designated as ID did not go above the
previously designated ID cutoff when given the LD on this occasion and therefore would
not have been diagnosed as ID in this study. The T60’s in these two individuals as well as
a third animal also did not exceed the designated ID cutoff when given the HD8.

3.5

Discussion
This study examines the effect of varying oral sugar dose (LD vs. HD), and either being

fed, or short term fasted in ID and NID horses. At the time, horses with basal insulin >30
ΜIU/ML and post-oral sugar insulin at 60-minutes > 45 ΜIU/ML (0.15 ML/kg BW dose)
were considered ID based on the 2018 Equine Endocrinology Group’s (EEG)
recommendation. The EEG released new recommendations in 2020 that indicated that
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following a higher dose (0.45 ML/kg BW dose) post-oral sugar insulin at 60-minutes > 65
ΜIU/ML was needed to indicate that the horse was ID. In study A, all ID horses would
have been diagnosed by the T60 timepoint (>45 ΜIU/ML) as being ID with either the FE
or FA treatment8,68; but the basal samples did not consistently differentiate. In study B, the
response to the higher OST dose was not statistically greater than that of the lower dose
suggesting no apparent advantage in these individuals of using the HD. With the LD, 6/8
ID horses were identified as ID (T60>45 ΜIU/ML); whereas the HD identified 5/8 horses
(T60 > 65 ΜIU/ML). In total, both the LD and HD identified 5/8 previously designated as
ID horses as ID8. This suggests that further work is needed to evaluate the cut off values
for the high dose in the horse compared with the pony21 especially due to the reported breed
differences in insulin dynamics25-27. The lack of the HD to produce higher insulin responses
in ID horses potentially could have been due to pancreatic endocrine exhaustion. Bertin et
al. (2018) however suggested that this is unlikely to occur, at least in the healthy horse, but
for the ID horse that is still unknown18. Lack of the HD to produce higher insulinemic
responses could also have been associated with seasonal influences. Data from our lab
indicated that summer (58.5 + 55.1 ΜIU/ML) had lower basal insulin levels compared to
winter (101.2 + 100.1 ΜIU/ML) and spring (120.7 + 142.5 ΜIU/ML)94. In addition, postOST (T60) values were also lower in the summer (102.1 + 67.7 ΜIU/ML) compared to
winter (182.1 +139.0 ΜIU/ML) and spring (202.8 + 139.8 ΜIU/ML)94. Therefore, the HD
needs to be evaluated in different seasons and at higher doses to determine if the cutoff,
determined in ponies, is appropriate for horses or if it needs to be raised.
In ponies, an overnight fast led increased insulin concentrations to the OST [12];
however, in the current study no differences were appreciated at T60 but basal insulins
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were lower in fasted horses compared to horses on pasture. This could be due to metabolic
differences between horses and ponies, as well as 3-hours not being a long enough duration
to exacerbate post-OST insulins in the horse as it was seen in the pony with an overnight
fast17. It is known that not all ID horses have fasted (no grain or hay), resting
hyperinsulinemia14,17,95. This was also found in the current study when all but one ID horse
(6/7; 85.7%) in the 3hr fasted group had basal insulins of <30 µIU/ML. The FE group had
ad libitum access to pasture forage (limited) and grass hay; however, one ID horse within
the FE group had equivocal basal insulins of 34.6 µIU/ML, although the other ID horses
had overt basal hyperinsulinemia. Since not all horses have resting hyperinsulinemia
measuring basal insulin alone has the potential of leading to misdiagnosis and therefore
dynamic tests are often recommended8. In unpublished data from our lab, we have shown
that 2 OSTs conducted 6-weeks apart in 12 ID horses resulted in a change in categorization
(ID, NID, equivocal ID) using basal insulin in 8/12 horses (67%); whereas the post-OST
insulin categorization only changed in 2/12 horses (17%). While basal insulins are a
convenient ambulatory practice for identifying ID horses, they may not be the most
accurate measurement of responsiveness to an oral hydrolysable carbohydrate load.
Ideally, when evaluating ID, it could be suggested that two dynamic tests would
need to be performed 1) to assess tissue insulin resistance (IR), and 2) to evaluate basal and
postprandial hyperinsulinemia7. Oral challenge tests, like the OST, mimic the natural,
physiological process of consuming feedstuffs. Karo Light Corn syrup is composed of
maltose and glucose. Previous studies have reported that the HD has 160.3mg sugar/kg
BW21. After consumption of a meal sweet taste receptors (T1R23) located on the tongue
and the section of the incretin hormones from the L and K cells in the small intestine initiate
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the absorption of glucose stimulating insulin secretion. The incretin response consists of
glucagon-like peptide-1 (GLP1) and glucose-dependent insulinotropic peptide (GIP) which
further increases insulin release9,92. Initially, the OST’s glucose and insulin responses were
reported to be positively correlated with the intravenous glucose tolerance test’s (IVGTT)
AUC for insulin12, but more recently work by Dunbar et al. (2016) suggested that whilst
the OST was highly specific (correctly identifying those with ID) it had low sensitivity
(misdiagnosing horses with ID) and in fact the combined glucose-insulin test outperformed
the OST in both specificity and sensitivity15. When the OST was compared to basal insulin
concentrations93; however, it showed greater sensitivity and was preferred over basal
insulins as a diagnostic test. Increased glycemic and insulinemic responses to the OGT
were associated with the development of laminitis13, and the OST has been shown to have
similar (85% agreeability) diagnostic power compared to the oral glucose test (OGT)25,26.
Improvements in tissue insulin sensitivity as determined by the frequently sampled
intravenous glucose tolerance test may not be mirrored by changes in the oral response to
a dietary challenge95. Therefore, it seems that whilst the OST does not evaluate tissue IR,
it is a practical, in-field diagnostic test which in a more standardized way mimics the
physiological response to oral hydrolysable carbohydrates. However, many factors can
affect the results of the OST, for example, forage composition96, time of day97, season94, in
horse variability19, dose of oral sugar17, fed/fasted status21, as well as insulin assay
used23,24,98,99. Several of these factors may have influenced the findings in this study.
Insulin responses vary throughout the year and there are seasonal changes in pasture
forage34,67,81. Borer et al. (2012), evaluated glycemic and insulinemic responses to different
oral carbohydrates during the four seasons and found that insulinemic responses to water
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soluble carbohydrates were higher in the fall compared to spring33. In the current study,
fed (access to effectively dry lot pasture and grass hay) and short-term fasted conditions
were only tested in the summer (August) whilst being fed a background of low NSC hay
and pasture (grass: 9.4 + 4.2% NSC on DM basis; n=50 samples from 2017-2018 over all
seasons and hay: 7.3 + 1.7% NSC on DM basis; n=26 samples from 2017-2018 over all
seasons). The effect of feeding and fasting may be influenced by seasonal access to higher
NSC providing feedstuffs. In addition, gastric emptying could have affected insulinemic
responses for both studies100. While horses did not receive grain on days where they were
not being sampled, they did have access to ad libitum grass hay and pasture forage
(limited). Any variation from gastric emptying; therefore, would come from individual
differences in gastric emptying rates. Weather was evaluated on all days that OSTs were
performed. All days were within the same temperature range (average 24 ̊ C vs. 25.5 ̊ C;
range 19 C – 29.4 ̊ C vs. 19 ̊ C – 31.7 ̊ C) and soil temperature (23.3 ̊ C) with no rainfall –
although it is impossible to state whether subtle differences in the environment in the period
before or during each test could have had any influence. Differences shown in the study
could also be the result of inter-individual variation in OST response. Frank & Walsh
(2017) found higher Cis around the mean for horses that had ID compared to those that
were NID19. Furthermore, Schuver et al. (2014) suggested that intra-assay CV (6%) for the
insulin assay (RIA) could have affected repeatability12. In the current study, the RIA used
had 7.4% and 6.3% intra- and inter-assay CVs, respectively. Future work should therefore
focus on continuing to evaluate factors that affect the OST. In addition, to the small number
of horses used, OSTs were not performed across multiple seasons and were performed once
and in the morning hours. It would be useful for future work to perform OSTs at various
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times of the day and across different seasons to determine if seasonal references ranges are
needed.
Whilst in this study the insulin response to the LD and HD did not statistically differ
for ID horses it was interesting to note that previously diagnosed ID horses would have
failed to be diagnosed by the LD (2/8; 28.6%) and HD (3/8; 37.5%) based on the latest
version of the Equine Endocrinology Group’s recommendation for diagnosis and
management of EMS8. In this recent version8, the cut-off recommendations for the original
dose remains the same, but the higher dose (0.45 ML/kg BW) has a cutoff value of > 65
µIU/ML with the recommendation that the HD be used in equivocal cases. For the LD, the
2 animals that did not exceed the agreed ID threshold on this occasion had T60 insulins of
34.02 µIU/ML and 38.0 µIU/ML compared with the other 6 whose T60 ranged from 56.5
– 283.8 µIU/ML (mean + SD: 146.3 + 92.1 µIU/ML). For the three horses that would not
have been diagnosed as ID using the new cutoff values for the HD their T60 ranged
between 53.9 – 62.5 µIU/ML (mean + SD: 56.9 + 4.9 µIU/ML) compared with the
remaining ID horses (n=5), range of 110.2 – 254.6 µIU/ML (mean + SD: 166.2 + 53.3
µIU/ML). This apparent change in categorization of the 3 horses could suggest that these
horses had

previously been misdiagnosed as ID; however, this is not likely because all 3

horses had shown clear ID basal (50.8, 56.7, 127.9 µIU/ML) and T60 (100.3, 138.0, 201.1
µIU/ML) insulin concentrations in the past (e.g. OST conducted 3 months prior). The
change could have reflected an improvement of their ID over the time between this latest
OST and the start of the study, during which time they could for example have lost adipose
tissue (regional & visceral). With the loss of fat mass and potential associated decreases in
leptin concentrations and increases in adiponectin concentrations, there could be an
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associated improvement in insulin sensitivity101,102. Weight loss is generally thought to
improve insulin sensitivity102; however, this is not always the case. Bamford et al. (2019)
for example found that weight reduction without exercise did not improve tissue insulin
sensitivity in obese animals although basal insulins did improve103. Similarly, Delarocque
et al. (2021) showed that weight gain resulted in decreased insulin sensitivity104; however,
Bamford et al. (2016) showed the opposite when horses became obese on a fat rich or sugar
rich diet but did report a decrease when fed a starch rich diet105. Horses in the current study
had not lost BCS in the past few months. Given their previous ID history it is possible that
they still had tissue insulin resistance but were no longer hyper insulin responsive to oral
hydrolysable sugars. Discrepancies between changes in oral and tissue insulin
responsiveness have been reported with dietary changes in older horses95 although in this
study the hyperresponsiveness to an oral sugar test remained despite improvements in
tissue insulin sensitivity. In addition, the time chosen to evaluate the post-OST insulin
potentially could have influenced the findings. Acceptable repeatability has been reported
for the OST at 75-minutes post-OST19; however, in our study the 60-minute post-OST
timepoint was used, as recommended8,20 which has been suggested to have relatively poor
repeatability21. Individual variability in insulin responses also occurs9. However, these
horses had clear OST results, using the T60 time point, designating them as ID on several
prior occasions suggesting that whilst poor repeatability/individual variability cannot be
completely excluded it is more likely that they should either no longer be classified as ID
or the cut-offs used for such classification need further evaluation. Further work is needed
in this area especially as two of these horses have subsequently been re-confirmed as ID
whereas the third has remained NID.
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3.6

Conclusion and recommendations
From the current study, it is confirmed that a low basal insulin does not rule out ID;

therefore, the work supports the recommendation that a dynamic OST is of value. When
not fasting prior to the OST, it is recommended that a low-NSC forage should be offered.
However, more work is needed to establish the optimal dose and thresholds especially for
the HD OST in horses and particularly in the more equivocal cases.
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Table 3.1 ID and NID Demographics.
Values presented are means + standard deviations. Age, body weight (BW), body condition
score (BCS), cresty neck score (CNS) for NID and ID horses in study A and B. Within a
row for study A, significant differences (P<0.05) are represented by different a, b
superscripts. Within a row for study B, significant differences (P<0.05) are represented by
different #, * superscripts.
Parameter

Study A

Study B

NID

ID

NID

ID

Age (years)

13.5 + 2.7 a

14.4 + 3.0 a

14.4 + 2.5 #

16.9 + 3.7 #

BW (kg)

573.0 + 55.8 a

625.9 + 86.0 a

564.1 + 66.7 #

534.2 + 103.8 #

BCS

4.8 + 0.7 a

6.4 + 0.8 b

5.6 + 0.7 #

6.9 + 0.9 *

CNS

0.8 + 0.4 a

2.5 + 1.1 b

1.2 + 0.4 #

2.8 + 1.2 *

Abbreviations: BW, bodyweight; BCS, body condition score; CNS, cresty neck score.

54

Table 3.2 Description of Insulinemic Responses.
Mean + SD [median] insulin concentrations for basal (T0), 60-minute post (T60), and delta insulin (DI) for all treatments: fed (FE) vs.
fasting (FA) and low-dose (LD) vs. high-dose (HD) on Sampling Day 1 and 2 Sampling Day 1 and 2 were 1-week apart and horses were
randomized to individual treatments on those days to have both treatment and metabolic groups represented equally on each sampling
day. Statistical significance is indicated by difference in columns by uppercase superscript in study A and lowercase superscript in study
B.
Study A

Study B

NID

#

Day 1
T0
(µIU/ML)
Day 2
T0
(µIU/ML)
Day 1
T60
(µIU/ML)
Day 2
T60
(µIU/ML)
Day 1
DI
(µIU/ML)
Day 2
DI
(µIU/ML)

ID

NID

ID

FE

FA

FE

FA

LD

HD

LD

HD

12.4 + 5.3
(10.8) A

9.2 + 2.1
(10.2) A

96.9 + 86.6
(64.3) B#

24.2 + 5.4
(23.3) A#

12.8 + 6.9
(11.7) a

15.2 + 7.6
(12.9) a

56.6 + 34.4
(43.9) b

33.8 + 16.2
(38.0) a

15.3 + 1.8
(15.4) A

8.5 + 1.3
(8.4) A

77.10 + 12.4
(74.9) B#

34.1 + 13.7
(29.2) A#

6.1 + 2.7
(5.1) a

12.6 + 3.5
(13.1) a

20.1 + 2.3
(20.1) b

28.7 + 1.5
(28.) a

12.1 + 1.5
(12.6) A

16.2 + 2.4
(16.36) A

179.5 +
128.6
(163.8) B#

87.9 + 24.8
(85.0) B#

21.6 + 9.7
(15.9) a

20.4 + 9.2
(18.7) a

141.6 + 97.5
(119.2) b

131.7 + 76.3
(133.7) b

24.4 + 2.9
(24.7) A

18.4 + 6.6
(15.4) A

174.6 + 51.5
(177.5) B#

118.9 + 28.2
(127.2) B#

13.3 + 3.5
(11.5) a

16.5 + 2.7
(15.5) a

49.9 + 22.5
(49.9) b

105.6 + 61.0
(105.) b

1.5 + 2.3
(0.5) A

7.0 + 0.9
(6.9) A

82.6 + 55.5
(94.0) B

63.7 + 26.8
(56.3) B

8.9 + 4.0
(7.8) a

5.2 + 2.7
(6.0) a

85.0 + 63.5
(75.4) a

97.9 + 67.1
(87.4) b

9.1 + 4.7
(9.3) A

10.0 + 7.3
(7.2) A

97.5 + 60.6
(102.6) B

84.8 + 23.6
(92.4) B

7.2 + 5.6
(6.0) a

4.0 + 3.5
(5.6) a

29.8 + 20.3
(29.8) a

77.0 + 62.5
(77.0) b

Indicates statistical difference within a metabolic group. Data represented as mean + standard deviations [medians].
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Figure 3.1 Fed & Fasting Insulinemic Responses.
Mean insulin concentrations +/- SEM for basal (T0), 60-minute post (T60), and delta
insulin (DI) for both the fed (FE) and fasting (FA) treatments. Differences within ID and
NID horses are indicated by different lowercase letters.

Insulin (µIU/ml)

250
e

200
150
100
50
0

a b
FE

FA

T0
f

FE

FA
ID

T60
DI

g

a b c

c
NID

56

e

f

d

Figure 3.2 Varying Oral Sugar Dose Insulinemic Responses.
Mean insulin concentrations +/- SEM for basal (T0), 60-minute post (T60), and delta
insulin (DI) for both the low (LD) oral sugar and high oral sugar dose (HD). Differences
within ID and NID horses are indicated by different lowercase letters.
160

e

e

Insulin (µIU/ml)

140

f

120
f

100
80

d

60

0

T60

d

40
20

T0

a

b

a b

c

LD

HD

DI

c
LD

NID

HD
ID

57

CHAPTER 4.
POSTPRANDIAL INSULIN RESPONSES TO VARIOUS
FEEDSTUFFS DIFFER IN INSULIN DYSREGULATED HORSES
COMPARED TO NON-INSULIN DYSREGULATED CONTROLS
This is the peer reviewed version of the following article: Macon EL, Harris P, Bailey
S, Barker VD, Adams A. Postprandial insulin responses to various feedstuffs differ in
insulin dysregulated horses compared with non-insulin dysregulated controls. Equine
Vet J. 2021 May 30. doi: 10.1111/evj.13474. Epub ahead of print. PMID: 34053111,
which has been published in the final form https://doi.org/10.1111/evj.13474. This
article may be used for non-commercial purposes in accordance with Wiley Terms
and Conditions for Use of Self-Archived Versions. This article may not be enhanced,
enriched or otherwise transformed into derivative work, without express permission
from Wiley or by statutory rights under applicable legislation. Copyright notices me
be removed, obscured or modified. The article must be linked to Wiley’s version of
record on Wiley Online Library and any embedding, framing or otherwise making
available the article or pages thereof by third parties form platforms, services and
websites other than Wiley Online Library must be prohibited.
4.1

Summary

Background: Controlling postprandial hyperinsulinemia is important in insulin
dysregulated (ID) horses to reduce the risk of laminitis.
Objectives: To evaluate postprandial insulin responses of ID vs. non-insulin dysregulated
(NID) horses to feedstuffs varying in non-structural carbohydrate (NSC) and crude protein
(CP).
Study Design: Randomized crossover.
Methods: 18 adult mixed-breed horses (13.3 + 2.2 years; 621 + 78.8 kg) were individually
fed (~1g/kg BW) specific feedstuffs within two crossover studies. 8ID & 8NID were used
in Study A and 11ID & 5 NID in Study B. Study A, all horses were randomly fed once:
cracked corn (CC: ~74% NSC & ~9% CP), ration balancer with low protein (RB-LP:
~15%NSC & ~17% CP), ration balancer with high protein (RB-HP: ~14% NSC and
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~37%CP), and 50:50 mixture of RB-LP:RB-HP (MIX-P). Study B, horses were randomly
fed once: CC, RB-HP, steam-flaked corn (SF: ~73% NSC & ~10%CP ), oat groats (OG
:~64%NSC & ~14% CP), and a low NSC pellet (L-NSC: ~6%NSC & ~12%CP). Blood
was collected for insulin determination (RIA) before and 30, 60, 75, 90, 105, 120, 150-,
180-, 210-, and 240-minutes post-feeding in study A and at 60-minutes in study B. Data
were analyzed via ANOVA for repeat measures post any required transformations.
Results: ID horses had significantly greater insulin responses (AUCi) than NID for all diets
in both studies (p<0.001; ID 22,362 + 10,298 µIU/ML·min & NID 6,145 + 1,922
µIU/ML·min). No effect of diet on AUCi for NID (p=0.2) but in ID the CC (32,000 +
13,960 µIU/ML·min) AUCi was higher than RB-LP (p=0.01; 18,977 + 6,731
µIU/ML·min). ID insulin (T60) was lower for the L-NSC (57.8 + 18.5 µIU/ML) vs. all
other diets (p<0.02; 160.1 + 91.5 µIU/ML).
Limitations: Small numbers of horses; no ponies.
Conclusions: NSC appears to be the main driver of the postprandial insulin response. ID
horses respond disproportionately to feeding even small amounts of low/moderate NSC
feedstuffs. Data on possible dietary thresholds for postprandial insulin responses cannot be
extrapolated from NID horses.

4.2

Introduction
Equine metabolic syndrome (EMS) describes a collection of risk factors that increase

the risk of laminitis1. Insulin dysregulation (ID) is the main, consistent component2 and is
a collective term for tissue insulin resistance, basal and postprandial hyperinsulinemia.
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Experimental insulin infusion can induce laminitis in healthy ponies and horses3,4 and
ingesting feedstuffs high in non-structural carbohydrates (NSC: starch + water-soluble
carbohydrates) can trigger endocrinopathic laminitis5,6. Recent work in the ID pony, has
suggested that the insulin response to oral sugars may be one of the most important
predictors of laminitis risk5. Therefore, controlling postprandial hyperinsulinemia is of
crucial importance due to its potential risk of inducing endocrinopathic laminitis.
Current management strategies to reduce the risk of laminitic episodes, especially in
horses with ID; therefore, include limiting NSC intake, increasing structured exercise, and
when necessary, using pharmaceuticals2. Dietary recommendations7 include feeding hay
with less than 10-12% NSC (on a dry matter [DM] basis) often combined with an
appropriate ration balancer to provide adequate overall amino acids, vitamin and mineral
intakes. The NSC recommendations; however, appear to have been extrapolated from work
with polysaccharide storage myopathy horses8 with limited published work directly
involving ID horses. To limit postprandial insulinemic responses in healthy horses, it has
been recommended that complementary feeds should either provide < 1.1 g starch/kg BW
or the meal limited to 0.3 kg/100 kg BW9.

Such recommendations have not been

established for the ID animal. Recently, ID horses fed 1.2g protein and 0.5g NSC/kg BW
had 9-fold greater insulin responses than healthy, NID horses10. The authors suggested that
protein (especially high in insulinogenic amino acids) intake therefore should also be
considered10. Balancer complementary feed11, fed in small amounts (e.g. 100g/100 kg BW)
are typically rich in protein and essential amino acids.
More information is therefore required with respect to the role of protein and NSC
in driving the insulin response in ID horses so that more targeted advice can be provided
60

to help reduce postprandial insulin responses. This may be especially important in the more
severely affected individuals, which are often overweight and being fed restricted foragebased diets with a balancer. Therefore, the following study evaluated the effect of feeding
small amounts of different feedstuffs varying in NSC and crude protein (CP), to determine
if ID horses produce greater postprandial hyperinsulinemic responses compared to NID
horses. Our hypothesis was that ID horses when fed small amounts of moderate to low
NSC providing feeds would have similar insulin responses to NID horses but would have
higher responses to feeding even small amounts of high NSC cereals.

4.3

Materials & Methods
Two separate crossover studies were undertaken: Study A during Summer 2017 and

Study B during the summer of 2018.
4.3.1

Horses

Overall, 18 adult horses (mean + SD: 13.3 + 2.2 years and 621 + 78.8 kg) of mixed
breeds, including Thoroughbred (n=2), Appaloosa (n=1), Paint (n=2), Thoroughbred cross
(n=2), Tennessee Walking Horse (n=1), Warmblood (n=2), Standardbred cross (n=2), and
unknown mix breed (n=6) were used. The horse demographics for each study are described
in Table 1. One-week prior to the study, body condition (1-9; BCS) and cresty neck score
(0-5; CNS) were determined for each horse by 3 personnel (experienced in assessing BCS
and CNS) and the average recorded 12,13. In addition, bodyweight (BW) was measured with
a calibrated portable agriculture scale (model 700, Tru Test Inc, Mineral Wells, TX). All
horses were considered to be non-PPID i.e. no signs of hypertrichosis and non-fall basal
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ACTHs (chemiluminescence immunoassay [Immulite® 1000]14) below the recommended
cutoff of < 30 pg/ML 1.
Study A used 8 adult horses with insulin dysregulation (ID) and 8 healthy, noninsulin dysregulated horses (NID, control group); Study B: 11 ID and 5 NID horses. Three
of the NID horses in Study A had become ID in the 12 months between the studies and 2
(1 ID and 1 NID) others had to be replaced for Study B due to unrelated medical issues
(i.e., lameness, ophthalmic issues). In order to categorize horses into their metabolic
groups, they underwent an oral sugar test (OST) 2 weeks prior to the beginning of each
study2. They were placed into 3.7 x 3.7 m individual pens and a basal blood sample was
taken via jugular venipuncture. Immediately after, 0.15 ML/kg BW of Karo Light Corn
Syrup (AHC Food Companies INC.) was administered orally. Sixty-minutes later another
venous blood sample was collected. Blood samples were processed within 3 hours of
collection. Blood was centrifugated at 800 g for 10 minutes, aliquoted and stored in -20 ̊ C
for determination of insulin concentration by Cornell University’s Animal Healthy and
Diagnostic Center (AHDC) endocrinology laboratory (Ithaca, NY) via commercially
available human insulin radioimmunoassay (RIA) (EMD Millipore Corp, Billerica, MA).
Horses with basal insulin >50µIU/ML, and/or 60-minute post OST insulin concentrations
> 45 µIU/ML were considered ID 1.
4.3.2

Study Design

Horses were group housed in 4-acre semi-dry lots (minimal grass and weeds) and
had ad libitum access to grass hay when they were not being sampled. During the 2 weeks
prior to the start of each study horses were acclimatized to pens (individual dry lot [3.7 x
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3.7 m]) and feedstuffs for approximately 1 – hour (0700-0800) each day. During this hour
they were fed 33% of the total ration of a particular treatment diet. In order to ensure all
horses used in the final study would eat all the diets the small meals of each diet were
provided in a random order to each horse in such a way that every horse sampled all of the
study diets at least twice and all diets were presented during the acclimation period.
For both studies blood was collected into 10 ML serum blood tubes and processed
within 1 – 2 hours after collection by centrifugation at 800 g x 10 minutes with the serum
being removed aliquoted, and frozen (-20 ̊ C).
a) Study A
Horses received 2 treatment diets each week over a 2-week period with 24hrs between
each treatment diet. For the rest of the week the horses were kept in their paddocks with ad
libitum access to grass hay. Horses were split into two groups (each group containing equal
number of ID and NID horses) and sampled 2 times per week. The order of diet provision
was randomized. On sampling days, horses were brought up into individual pens (07000800) and a basal blood (T-1) sample taken via jugular venipuncture. Immediately
following T-1, an intravenous catheter (16 g x 5-inch; Covetrus) was placed aseptically
into the jugular vein. Thirty-minutes after catheter placement, a second basal blood (T0)
sample was taken via the catheter port. The individual treatment diets were then given and
consumed by all horses within ~10 minutes. After each diet had been consumed, timers
were set, and blood was collected at 30, 60, 75, 90, 105, 120, 150, 180, 210, and 240minutes postprandially.
b) Study B
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Horses received weekly (same day each week) a different diet, in a randomized order
on sampling days. All horses were sampled at the same time (minutes apart). All diets were
fed on this day after horses had been brought up into their individual pens (0700-0800). A
basal blood (T0) sample was initially taken by jugular venipuncture followed by the
immediate offering of the treatment diet. After the consumption of the treatment diet (~10
minutes), a timer was set for blood to be collected 60-minutes postprandially. Both samples
were collected via jugular venipuncture. For the rest of the week the horses were kept in
their paddocks with ad libitum access to grass hay.
4.3.3

Diets

Four treatment diets (1.02 + 0.1 g/kg BW) were fed in study A and 5 (1.25 + 0.1
g/kg BW) in study B (Table 2). Diets were provided in a random order to the horses and
all diets were represented each day. All treatment diets, grass hay, and pasture were
sampled weekly and sent to Equi-Analytical Laboratory (Dairy One Forage Laboratory,
Ithaca, NY) for analysis via wet chemistry.
a) Study A: The ration balancer with high protein (RB-HP) was a commercially
available high protein balancer (Buckeye Nutrition, Dalton, Ohio) and was fed
based on manufacturer’s daily intake recommendation. All other diets were fed
at the same rate. The ration balancer with lower protein (RB-LP; Buckeye
Nutrition) had been formulated to have a similar NSC to the RB-HP but a lower
protein content. The RB-HP and the RP-LP were then mixed to provide a mixed
ration balancer with moderate protein (MIX-P). The cracked corn (CC;
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Woodford Feed Company Inc, Versailles, KY) was mixed with 60 ML of
molasses to increase palatability and was used as a positive control.
b) Study B: The same RB-HP was used along with the CC and a specifically
formulated low NSC pelleted feed (L-NSC). In addition, in order to evaluate
the insulin response to more pre-cecally digestible starch (than in CC), steamflaked corn with 60 ML of molasses (SFC), and oat groats (OG) were also fed.
4.3.4

Assays

Insulin was analyzed by Cornell University’s AHDC endocrinology laboratory via
human insulin radioimmunoassay (RIA) (EMD Millipore Corp, Billerica, MA) and
run-in duplicates 2. The sensitivity of the assay, as reported by the manufacturer is
2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation were 7.4
and 6.3%, respectively.
4.3.5

Data analysis

Statistics were run on Minitab Software 19.0 (Minitab LLC, PA, USA). To evaluate
differences in T-1 vs. T0 insulin in Study A, a T-test was performed. Prior to running all
general linear models (GLM), normal homoscedasticity and residuals were confirmed. If
GLM assumptions did not pass, data were logged transformed. Study A response variable
was area under the curve for insulin (AUCi) with explanatory variable as metabolic status
(ID vs. NID). With a significant difference in AUCi between ID and NID groups, metabolic
groups’ AUCi (response variable) were separated with dietary treatment set as the
explanatory factor. Significant differences between diets were determined with a Tukey
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post-hoc analysis. For study B, data were not normal even after log transformation. Insulin
responses from each group had drastically different distributions. Therefore, Moon’s
Median test was ran with response variables of basal (T0), postprandial insulin (T60), and
delta insulin and metabolic group as the explanatory variable. Nonparametric test
confirmed that ID (median = 3.9) was different from NID (median = 2.6). GLM
assumptions were met when metabolic groups were separated. The response variables were
T0, T60 and delta insulinemic responses and explanatory variable was dietary treatment.
Differences in dietary treatment were determined by Tukey post-hoc analysis. For all
analyses, statistical significance was considered at p<0.05 and trends at p<0.10.

4.4

3. Results

All horses remained healthy throughout both studies.
4.4.1

Study A

There was no difference in insulin concentrations between T-1 and T0, data not
shown) and no negative behavioral patterns were seen in response to catheter placement.
Age, BW, BCS were not different between ID and NID horses (p>0.5); however, CNS and
basal and 60-minute post-OST (T60) insulin were different between ID and NID horses
(p<0.001; Table 1). Pasture and grass hay analysis did not change significantly throughout
the study (p<0.5). CP in pasture and hay was 20.1 + 0.5% and 12.7 + 1.8% on a DM basis,
respectively. NSC in pasture and hay was 9.4 + 1% and 6.7 + 0.5% on a DM basis,
respectively. Basal (T0) insulin concentrations were different between ID (59.75 + 39.64
µIU/ML) and NID (17.55 + 5.98 µIU/ML) horses (p<0.001) for all diets; however, basal
66

insulin concentrations were not different between diets within the ID (p=0.7; CC 67.4 +
50.2 µIU/ML; RB-HP 68.2 + 53.8 µIU/ML; RB-LP 48.97 + 22.83 µIU/ML; MIX-P 54.42
+ 26.63 µIU/ML) and NID (p=0.4; CC 16.28 + 3.94 µIU/ML; RB-HP 19.65 + 6.13
µIU/ML; RB-LP 15.39 + 3.31 µIU/ML; MIX-P 18.89 + 8.94 µIU/ML) horses. The AUCi
were significantly higher for all treatment diets in ID compared to NID horses (p<0.001;
Table 3). The AUCi were not affected by dietary treatment in the NID horses (p=0.2; Figure
1a) but for the ID horses the AUCi for CC was significantly higher than for RB-LP
(p=0.01). In addition, there was a trend for CC to be higher than MIX-P (p=0.06). The
insulin concentrations were significantly higher in response to feeding the CC than RB-LP
in the ID horses at 90, 105, 120, 150, 180, 210, and 240-minutes (p<0.05 Figure 1b). The
concentrations in response to feeding the CC were also significantly higher than the MIXP in ID horses at 120 and 180-minutes (p<0.05) and there was a trend to be higher at 90,
105, 150, and 210 minutes (p<0.1). Starch and NSC (g/kg BW) were different between any
diet (p=0.02; Table 4a).
4.4.2

Study B

Similar to study A, there were no differences in age, BW and BCS between NID and
ID horses (p>0.5); however, there were differences in CNS, basal and T60 insulin
concentrations between NID and ID horses (p<0.001; Table 1). Basal insulin
concentrations were higher in ID horses compared to NID (p<0.001; Table 4b); however,
there were no differences in basal insulin concentrations within ID or NID horses (p=0.5
and p>0.9, respectively; Table 4b). Sixty-minute postprandial and delta insulinemic
responses (60 min minus basal insulin concentrations) were significantly higher in ID than
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the NID horses for all diets (p<0.001; Figure 2 and 3; Table 4b). There was a trend for a
greater insulin response in the NID to OG compared to L-NSC (p=0.06). Delta insulin
responses for NID horses were significantly higher for OG vs. CC (p=0.038; Figure 5) and
there was a trend for them to be higher in response to feeding SFC compared to CC
(p=0.081). The ID horses’ postprandial (T60) responses were significantly lower for LNSC compared to OG, SFC, and CC (p<0.02); however, the response to the L-NSC was
not different from the response to RB (p=0.1) and there was no significant difference
between OG, CC and SFC (p>0.4). Delta insulinemic response values for ID horses were
significantly lower for the L-NSC dietary treatment compared to all other diets (p<0.001).
Starch and NSC (g/kg BW) were different between any diet (p<0.03; Table 4b).

4.5

Discussion
Although there are multiple studies that have recorded both glycemic and

insulinemic responses to varying feedstuffs in the healthy, NID horse 9, 15-18, very little has
been reported specifically in the ID animal

10,19

. This study however, confirmed that ID

horses’ insulinemic responses to feedstuffs varying in NSC and CP are significantly
different from NID horses and therefore, data obtained from NID horses cannot be
automatically transferred to the ID animal.
Several factors influence insulinemic responses in the horse, for example
composition of the diet 9, the rate of gastric emptying determined by meal size 15, the rate
of consumption 21, as well as differences in the methodology used to measure insulin 22.
Previous work also suggested that there might be a threshold for NID horses above which
significant insulin responses would be found. Vervuert et al. (2009), for example, fed
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increasing amounts of starch and found that feeding >1.1g starch/kg BW produced
disproportionate peak insulin responses (1.1g starch/kg BW: 162 + 32 ΜIU/ML at 188 +
105 minutes vs. 0.8g starch/kg BW: 88 + 69 ΜIU/ML at 225 + 39 minutes) in healthy
horses. Similarly, Zeyner et al. (2017) found that insulin responses were highest with a
meal containing >1 g starch/kg BW. Study A: therefore, confirmed that feeding small
amounts (~1g/kg) of restricted NSC (~9-17% NSC) containing feedstuffs to NID horses
(which all provided <1g starch/kg BW) produces little insulin response (Table 4a).
Recently a study provided evidence that the insulin responses of ID horses are
different to those of healthy individuals when fed the same forages19 and supported the
current recommendations to feed forage with less than 10-12% NSC (on a dry matter [DM]
basis) to laminitis prone horses. The insulinemic responses to the feeding of forage 8,
however, may not be directly applicable to the feeding of complementary feeds, which are
typically ingested more quickly than forages 23, can provide greater NSC intakes and, due
to likely increased NSC availability within the foregut, are more likely to induce enhanced
circulating glucose and thereby insulin concentrations

24,25

. This present; therefore,

importantly showed that even feeding the small amounts of the various diets in study A
produced 1.7 – 3.4-fold greater postprandial insulinemic responses in the ID horses
compared to the NID horses. It has been suggested that insulin dysregulation may have at
least in part a gastrointestinal etiology 26. The enhanced metabolic response by the ID horse
could be due to more glucose being absorbed from the feedstuff, a lack of metabolized
insulin through the first pass of the liver, abnormal intestinal glucose transport, or the
pancreatic insulin response being augmented by increased incretin secretions 26. Bamford
et al. (2015) showed a positive association between post prandial insulin concentrations
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and GLP-1 and in future studies concurrent evaluation of the incretin response may be
beneficial to help understand the drivers of this enhanced insulin response in ID horses.
Study A also suggested that, at least for the range of concentrations provided, the main
nutritional factor driving the insulin response was NSC rather than protein content in that
it evaluated 4 treatment diets with 4 different CP (36.9, 16.8, 26.3, and 9.3% DM) and 2
NSC (14.3, 14.9, 15.3, and 74.4% DM respectively) concentrations. The CC (74% NSC)
dietary treatment produced the highest AUCi and there were no significant differences in
the responses between RB-HP, RB-LP, and MIX-P
As starch in ground corn is not very pre-cecally available for digestion by
mammalian enzymes in the small intestine, alternative grains with more pre-cecally
available starch (i.e., oat groats and steam-flaked corn)

28

were included in study B to

further evaluate differences. Delta insulinemic responses ([T60 insulin] – [T0 insulin])
provide information as to the responsiveness of that individual to the specific diet
especially in those with high resting insulin concentrations. The delta response refers to the
increase in insulin concentration after the consumption of a meal (i.e., the metabolic
response)

26

. In the NID horses there was a trend for a greater insulin response with the

oats and steam-flaked corn, but the differences were not marked (and all increases were
<30µIU/ML in all NID horses across all diets). However, in the ID horses the delta
insulinemic response increase was significantly higher (Mean + SD; CC:111.2 + 64.4
µIU/ML, DO: 95.4 + 67.3 µIU/ML, RB: 63.1 + 38.6 µIU/ML, SFC: 117.3 + 75.1 µIU/ML)
for all feeds other than the L-NSC (~6%NSC: 10.32 + 16.11µIU/ML), although the actual
T60 values reached were not significantly different between the L-NSC and the RB-HP
diet (~14.3%NSC; Table 4a & 4b).
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Whilst evaluating AUCi provides information with respect to the overall response
to a diet this is obviously not practical to undertake in a field situation; therefore, Study B
evaluated the response to the feeds in a similar way to the OST. This enabled not only the
value at 60-minutes to be compared between ID and NID but, more importantly, the extent
of any individual dietary response i.e., the delta response as discussed above. If the L-NSC
diet is excluded from the evaluation (as it produced a significantly lower response even in
the ID animal) and using the same time points in both study A and B: the overall delta
responses for NID horses in study A and B were 17.6 + 12.3µIU/ML (1.2 – 35.3 µIU/ML)
and 12.3 + 5.4 µIU/ML (15.8 – 21.6 µIU/ML), respectively and for the ID horses were
59.0 + 33.7µIU/ML (15.0 – 110.6µIU/ML) and 97.4 + 23.3µIU/ML (28.7 –
205.5µIU/ML), respectively . This suggests that a normal delta response to meals fed at ~1
g/kg BW with a NSC content >14% (DM) might typically be < 35µIU/ML in NID horses.
In the ID horses however, there was considerable variability in the delta insulin levels. For
example, some horses showed a larger delta value after consuming the oat groats feed
(>100 µIU/ML) than with the oral sugar test, while others showed a greater response at 60
mins with the OST (data not shown). Therefore, different horses may respond differently
to certain diets, which could partly be related to the time taken to digest the feed
(differences in Tmax), and/or their individual ability to digest that sugar/starch
composition/intake level, processing type of cereal grains 32, 33, 34, as well as differences in
cereal grains 15. This does suggest that the individual response to a feedstuff or even the
ranking of responses within a group cannot automatically be presumed from the OST
results. Furthermore, significant variability in insulin responses to the OST have been noted
in previous studies 29-31.
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Study B confirmed that meal feeding itself does not induce a marked insulin
response in ID horses as feeding small quantities of starch (0.024 g/kg BW) and NSC (0.08
g/kg BW) in a meal provided at ~1g/kg BW produced little insulin response. However,
feeding just over twice this at 0.054g starch/kg BW and 0.191g NSC/kg BW resulted in an
increased insulinemic (delta) response. This suggests that if a very low insulin postprandial
response is required to minimize endocrinopathic laminitis risks 5, ID horses may have a
threshold of intake for starch somewhere between 0.024-0.054g/kg BW and for NSC
between 0.076-0.191g/kg BW, and a dietary NSC content somewhere between 6 and ~
14%NSC (DM basis). This does support the current recommendations of feeding diets with
an NSC less than 10-12% DM 35 even if only feeding small amounts per meal – although
from the current study it is not possible to confirm where exactly between 6-14% the
threshold may be. There was a large individual variability in the insulin response when the
ID horses were fed all the diets apart from the L-NSC. Given that previous work has
suggested that the extent of any increase may reflect laminitis risk 5, the threshold of NSC
that can be fed and not produce a significant insulin response may vary with the severity
of the ID or other currently unknown factors.
In addition to whether there is a threshold of NSC that can be fed to ID horses
before a significant insulin response is produced there is also a question whether there is a
specific insulin threshold with respect to laminitis risk. Possible suggestions for a threshold
around ~ 200 µIU/ML have been extrapolated from a few studies

4-5

; although it is not

known whether such values have to be maintained for a certain period of time or repeated
a certain number of times for laminitis to occur or what if any other contributory factors
are required. In one recent experimental study in Standardbred horses, insulin
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concentrations sustained at a level between 300-500 µIU/ML caused them to develop
laminitis within 24-30 hours 36. The T60 insulin values when the ID horses were fed steam
flaked corn were 187.9 + 107.0µIU/ML with a range of 67.7 – 377.0 µIU/ML. Three ID
horses had insulin concentrations >250 µIU/ML; therefore, at least at this one time point it
is not possible to say how long any individual had such values or what the actual peak
values might have been in any animal. No adverse clinical signs were seen during the study
or in the weeks afterwards. One individual horse also had insulin values that ranged from
223.3 µIU/ML to 354.8 µIU/ML between 30 and 150-minutes post CC ingestion and yet
did not show any signs of laminitis during the study or at least 3 months after the
completion of the study.
Limitations in the current study were the relatively small number of horses used
and the absence of ponies. Given that ponies and horses have different glucose and insulin
dynamics 37, 38, 39, it would be prudent to identify the threshold for NSC in the pony. In the
future, other hormones, like glucagon-like peptide 1 and 2, could also be measured to better
understand the metabolic response of the ID horse. Until further information on the factors
that link insulin response to laminitis risk is available, it would seem sensible to limit post
prandial insulin responses especially in those horses prone to laminitis. Given the
variability in individual responses to diet it would seem to be a practical managemental
tool, in the meantime, to recommend that the insulin responses pre- and 60-minutes post
ingestion of at least an individual’s normal complementary feed would be worth
monitoring especially in those identified to be ID or at increased risk of laminitis.
Appropriate dietary and managemental changes could then be instigated. With this in mind,
it is important to note that in this study the whole daily ration of the balancer was given as
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one meal rather than in divided doses as commonly recommended. Other pilot work has
suggested that even in severe ID horses, low insulin responses may be produced when fed
a high protein low-NSC-providing balancer in smaller amounts i.e. < 0.5g/kg BW/meal
(unpublished data). Further work, however, is required to determine what is the upper limit
of NSC (taking size of meal as well as %NSC into consideration) for the ID horse in order
to minimize any increases in insulin postprandially. In conclusion, the current threshold for
a NSC intake in the ID horse that will not consistently result in a clinically relevant
insulinemic response is unknown and further work is needed in this area.
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Table 4.1 ID and NID Demographics.
Values presented are means + standard deviations. Age, body weight (BW), body condition score (BCS), cresty neck score (CNS), and
insulin responses to the oral sugar test (OST) for NID and ID horses in study A and B. Within a row for study A, significant differences
(P<0.05) are represented by different a, b superscripts. Within a row for study B, significant differences (P<0.05) are represented by
different #, * superscripts.
Parameter

Study A

Study B

NID

ID

NID

ID

Age (years)

12.6 + 1.4 a

14.3 + 2.6 a

13.8 + 1.8 #

14.6 + 2.8 #

BW (kg)

613.6 + 79.3 a

618.8 + 92.7 a

564.6 + 79 #

612.4 + 84 #

BCS

6.3 + 1.1 a

7.1 + 0.6 a

7.1 + 0.6 #

6.3 + 1.1 #

CNS

1.5 + 0.4 a

2.7 + 0.7 b

1.3 + 0.3 #

2.5 + 1.2 *

19.7 + 6.4 a

86.6 + 53.0 b

13.6 + 4.8 #

57.7 + 22.1 *

39.4 + 15.6 a

157.6 + 60.4 b

19.6 + 8.2 #

126.6 + 48.3 *

OST – T0 Insulin
(µIU/ML)
OST – T60 Insulin
(µIU/ML)

Abbreviations: BW, bodyweight; BCS, body condition score; CNS, cresty neck score; OST, oral sugar test.
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Table 4.2. Wet Chemistry Analysis of Diets for Study A and B.
All values are presented on a DM basis; Mean + SD. Crude protein (CP), starch, watersoluble carbohydrates (WSC), and non-structural carbohydrates (NSC) content of the
feedstuffs are shown for study A and B.
Feedstuff

CP%

Starch%

WSC%

NSC%

Study A
Ration
Balancer-High

36.9 + 0.1

4.8 + 0.7

9.3 + 0.3

14.1 + 0.8

16.8 + 1.4

9.5 + 1.2

5.4 + 0.3

14.9 + 1.5

26.3 + 0.7

7.3 + 0.1

7.4 + 1.2

14.7 + 1.1

9.3 + 0.0

65.5 + 1.6

8.95 + 0.2

74.4 + 1.5

Protein
Ration
Balancer-Low
Protein
Mixed Ration
Balancer –
Moderate
Protein
Cracked Corn
w/ Molasses

Study B
Ration
Balancer-High

36 + 1.0

4.5 + 0.3

10.3 + 1.0

14.8 + 0.7

9.6 + 0.1

63.8 + 1.6

8.1 + 0.3

71.9 + 1.3

9.8 + 0.6

68.1 + 2.6

4.9 + 2.8

73.0 + 0.2

Oat Groats

13.9 + 0.1

61.2 + 0.3

3.1 + 1.0

64.3 + 0.7

Low NSC

12.0 + 0.1

1.7 + 0.4

4.5 + 0.4

6.1 + 0.1

Protein
Cracked Corn
w/ Molasses
Steam-Flaked
Corn w/
Molasses

Abbreviations: CP, crude protein; WSC, water soluble carbohydrates; NSC, non-structural
carbohydrates; LOW, formulated low NSC pellet.
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Table 4.3 AUCi for NID and ID horses for Study A.
Values presented are mean + standard deviations. AUCi for all dietary treatments for study
A for NID and ID horses.
NID

ID

AUCi

AUCi

(Μiu/ML · min)

(Μiu/ML · min)

CC

7,329 + 2,017 A, a

32,000 + 13,960 Ab

RB-HP

5,966 + 1,753 A, a

22,069 + 7,142 AC, b

RB-LP

5,379 + 1,416 A, a

18,977 + 6,731 BC, b

MIX-P

5,906 + 2,198 A, a

16,403 + 4,304 AC, b

Dietary Treatment

Within a row, significance (P<0.05) is represented by different lowercase superscripts.
Within a column, significance (P<0.05) is represented by different uppercase superscripts.
Abbreviations: AUCi, Area under the curve for insulin; CC, cracked corn with molasses;
RB-HP, ration balancer with high protein; RB-LP, ration balancer with low protein; MIXP, mixed ration balancer with moderate protein.
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Table 4.4 Peak Insulin Concentrations for NID and ID Horses with Starch and NSC Intakes in study A.
Values presented are means + standard deviations.
Basal Insulin (ΜIU/ML)
Peak Insulin (ΜIU/ML)
Dietary
Starch g/kg NSC
Treatment BW
BW

g/kg

NID

ID

NID

ID

RB-HP

0.052 C

0.146 B

19.7 + 6.1

68.2 + 53.8

39.0 + 16.0

127.6 + 35.7

RB-LP

0.097 B

0.152 B

18.9 + 8.9

49.0 + 22.8

34.1 + 14.2

112.2 + 34.8

MIX-P

0.075 BC

0.156 B

15.4 + 3.3

54.4 + 26.6

30.6 + 8.6

111.0 + 24.1

CC

0.668 A

0.759 A

16.3 + 3.9

67.4 + 50.2

39.7 + 14.9

173.1 + 61.6

Within a row, significance (P<0.05) is represented by different lowercase superscripts. Within a column, significance (P<0.05) is
represented by different uppercase superscripts.
Abbreviations: CC, cracked corn with molasses; RB-HP, ration balancer with high protein; RB-LP, ration balancer with low protein;
MIX-P, mixed ration balancer with moderate protein.
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Table 4.5 Insulin Concentrations for NID and ID Horses with Starch and NSC Intakes in Study B.
Values presented are means + standard deviations.
Basal Insulin (ΜIU/ML)

T60 (ΜIU/ML)

Dietary
Treatment

Starch g/kg
BW

NSC g/kg
BW

NID

ID

NID

ID

RB-HP

0.054 A

0.191 C

14.3 + 4.6

57.2 + 33.4

21.5 + 6.8

125.7 + 62.6

CC

0.783 C

0.886 B

14.1 + 3.8

48.5 + 15.1

20.8 + 6.8

159.7 + 78.1

SFC

0.874 B

0.910 B

15.1 + 2.6

70.6 + 48.6

30.5 + 12.2

187.9 + 107.0

OG

0.761 C

0.799 B

13.9 + 3.6

74.3 + 51.7

32.1 + 10.1

169.7 + 111.7

L-NSC

0.024 A

0.076 A

14.5 + 4.4

44.4 + 16.0

17.2 + 4.4

57.8 + 18.5

Within a row, significance (P<0.05) is represented by different lowercase superscripts. Within a column, significance (P<0.05) is
represented by different uppercase superscripts.
Abbreviations: CC, cracked corn with molasses; RB-HP, ration balancer with high protein; RP, research pellet, SFC, steam-flaked corn
with molasses; OG, oat groats; L-NSC, low NSC pellet.
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Figure 4.1a. Non-Insulin dysregulated (NID) insulin responses, Study A.

Mean insulin concentrations + SEM prior to (T-1 min) and following 240-min responses
to four dietary treatments of ration balancer (RB), cracked corn (CC), research pellet (RP),
and mix treatments. No significant differences in AUCi for NID horses (P=0.215).
Figure 4.1b. Insulin dysregulated (ID) insulin responses, Study A.

Mean insulin concentrations + SEM prior to (T-1 min) and following 240-min responses
to four dietary treatments of ration balancer (RB), cracked corn (CC), research pellet
(RP), and mix treatments. CC was significantly higher than RB-LP (P=0.011)
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Figure 4.2. Postprandial insulin concentrations in non-insulin dysregulated (NID)
and insulin dysregulated (ID) horses in Study B.

Mean insulin concentrations + SEM for postprandial insulin (T60) for five dietary
treatments of cracked corn with molasses (CC), oat groats (OG), low NSC pelleted feed
(LNSC), ration balancer (RB) with high protein, and steam-flaked corn (SFC). All ID
horses’ T60 responses were different than NID horses (P<0.001). Significance is denoted
by difference of superscript.
Figure 4.3. Delta insulin concentrations for non-insulin dysregulated (NID) and
insulin dysregulated (ID) horses in Study B.

Mean insulin concentrations + SEM for delta insulin (DI) for five dietary treatments of
cracked corn with molasses (CC), oat groats (OG), low NSC pelleted feed (LNSC), ration
balancer (RB) with high protein, and steam-flaked corn (SFC). All ID horses’ DI responses
were different than NID horses (P<0.001). Significance is denoted by difference of
superscript.
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CHAPTER 5. IDENTIFYING POSSIBLE THRESHOLDS FOR NONSTRUCTURAL
CARBOHYDRATES IN INSULIN DYSREGULATED HORSES
5.1

Abstract
Feeding recommendations for the insulin dysregulated (ID) horse are scarce.

Identifying the intake level of nonstructural carbohydrates (NSC) that limits the
postprandial insulinemic response may help reduce the risk of hyperinsulinemia-associated
laminitis (HAL). Sixteen horses (8 ID; 16.1 + 2.0 years and 577.3 + 121.4 kg & 8 noninsulin dysregulated, NID; 17.3 + 3.8 years and 574.1 + 64.7 kg) were randomly fed eight
dietary treatments in crossover design. Dietary treatments were composed of a base pellet,
low-nonstructural carbohydrate diet (LNSC; 0.04 g of water-soluble carbohydrates
(WSC)/kg BW & 0.01 g of starch/kg BW), and the addition of pure sources of either sugar
(dextrose) or starch (50:50 mix of waxy-maize and oat starch powder) titrated to create
increasing amounts of either WSC: TX2 (0.06 g WSC/kg BW), TX4 (0.08 g WSC/kg BW),
TX6 (0.11 g WSC/kg BW), TX7 (0.17 g WSC/kg BW) or starch: TX3 (0.03 g starch/kg
BW), TX5 (0.06 g starch/kg BW), TX8 (0.10 g starch/kg BW). Horses were fed each
dietary treatment at a rate of 1 g/kg BW once. Blood samples were collected, via jugular
catheters placed aseptically under local anesthetic before and 30, 60, 75, 90, 105, 120, 150,
180, 210, and 240-minutes following diet consumption. Insulin was determined via RIA
and diet analytes were determined via wet chemistry. Statistical analysis was performed in
Minitab Software and data were analyzed with a mixed effect model. Positive incremental
area under the curve for insulin (IAUCi) was calculated for all horses and dietary
treatments. There was no significant effect of diet in NID horses. ID horses IAUCi were
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significantly different to NID IAUCi for TX6, TX 7 & 8 (p<0.04). For ID horses IAUCi
for TX6 was different than for LNSC (p<0.01), but not different than TX5 (p>0.05). Based
on this study, using supplemental pure starch and sugar sources, ID horses seem to have an
apparent threshold for NSC of 0.10 – 0.13 g/kg BW, above which significantly increased
insulin responses are seen compared to NID horses.

5.2

Introduction
Equine metabolic syndrome (EMS) is associated with an increased risk of

hyperinsulinemia-associated laminitis (HAL) 8. ID, a collective term for both basal and
postprandial hyperinsulinemia and tissue insulin resistance, is the most consistent
characteristic of EMS 8. Other factors associated with EMS are increased general or
regional adiposity, hypertriglyceridemia, hypertension, abnormal adipokine and incretin
concentrations. In a herd of ponies with ID and some having concurrent pituitary pars
intermedia dysfunction (PPID), endocrinopathic laminitis (EL) or HAL was associated
with the consumption of large amounts of hydrolysable carbohydrates 13 and the individual
animal’s risk of developing laminitis was associated with their insulin response to both an
OGT and a challenge diet (12 g NSC/kg BW/day). It is commonly recommended that
dietary management, specifically minimizing postprandial insulinemic responses to
feedstuffs may reduce the risk of HAL in ID horses
experience HAL are obese
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59

. Whilst not all EMS horses that

and lean animals can be ID, often owners are having to

manage to prevent weight gain or commonly encourage weight loss in their ID animals;
therefore, feeding low non-structural carbohydrate (NSC: starch + water soluble
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carbohydrate) feedstuffs such as vegetable oil/fat that do not promote an insulin response
are not appropriate and alternatives are needed 59,107.
Feeding recommendations for EMS (i.e., ID) horses were originally adapted from
a study conducted in horses with polysaccharide storage myopathy, where researchers
found that feeding forage with < 12% NSC (DM basis) would reduce postprandial
insulinemic responses

47

. In addition, Vervuert et al. (2009) found that feeding < 1.1 g

starch/kg BW would result in lower glycemic and insulinemic responses in healthy horses
108

. However, neither of these studies were conducted in the ID animal, although

recommendations were developed from them.
If ID animals require minimal postprandial responses to avoid HAL, recent work
has shown a possible threshold for starch of between 0.024 and 0.054 g/kg BW and for
NSC of between 0.076 – 0.191 g/kg BW in ID horses that would reduce the risk of HAL
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. Thus, the current study aimed to elucidate if ID horses do indeed have a threshold for

NSC, specifically water-soluble carbohydrates (WSC) and starch, by evaluating the insulin
response to eight different diets that varied in their WSC and starch content.

5.3
5.3.1

Methods and Materials
Horses

Overall, 16 horses, 8 NID (17.3 + 3.8 years and 574.1 + 64.7 kg) and 8 ID (16.1 +
2.0 years and 577.3 + 121.4 kg) of mixed breeds, including Thoroughbred (n=5),
Appaloosa (n=1), Paint (n=2), Quarter Horse (n=2), Tennessee Walking Horse (n=2),
Thoroughbred Cross (n=1), and unknown breed (n=3) were used. Two ID horses were
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removed from the study due to health reasons not associated with the treatment diets. Twoweeks prior to sample collection, at the beginning of the spring season, all horses
underwent an oral sugar test (OST) using the 0.15 ML/kg BW dose. Using published
criteria, the horses were confirmed as being either NID or ID1. Overall (mean ± SD) the
NID horses’ basal serum insulins were 17.1 + 6.3 µIU/ML and their post-OST serum
insulins were 22.1 + 4.26 µIU/ML; the ID horses’ basal serum insulin were 48.5 + 15.3
µIU/ML and post-OST serum insulins 95.9 + 38.1 µIU/ML. In addition, horses were
assessed to confirm they had no signs of pituitary pars intermedia dysfunction (PPID) and
their non – fall plasma ACTH concentrations were < 30 pg/ML (NID: 19.9 + 6.9 pg/ML;
ID: 21.2 + 8.2 pg/ML) 71.
5.3.2

Treatment Diets

One-week prior to sample collection the first week of sample collection,
bodyweight was measured via a portable calibrated agriculture weigh scale (model 700,
Tru Test Inc). All the treatment diets were fed at 1 g/kg BW based on this original weight.
The treatments diets were based on the control low non-structural carbohydrate (LNSC)
fiber-based pellet to which varying amounts of either a pure source of glucose (D-(+)glucose, dextrose, Sigma Aldrich) or a 50:50 mix of oat starch (True Nutrition, CA, USA)
and waxy maize starch (True Nutrition, CA, USA) were added. The LNSC pellet was
composed of soybean hulls, dried beet pulp, dehydrated alfalfa meal, and soybean oil and
its nutrient content can be found in Table 1. The LNSC pellet (negative control) had
previously been shown not to cause an exacerbated insulinemic response based on previous
work 109. The oat starch was composed of 12.7% crude protein (CP), 2.1% water-soluble
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carbohydrates (WSC), 1.4% ethanol-soluble carbohydrates (ESC), and 64.5% starch on a
DM basis. The waxy maize starch was composed of 0.2% CP, 0.7% WSC, 0.4% ESC, and
97.1% starch on a DM basis. All treatment diets were formulated to keep the CP intake
constant and either increase starch or WSC. Thus, dietary treatments (TX) 3, 5, and 8 had
increasing concentrations of starch whilst the WSC was held constant and TX 2, 4, 6, and
7 had increasing concentrations of WSC whilst holding starch constant. These doses of
starch and sugar were selected to fall within the range 6-15% NSC based on a previous
study109. A detailed list of nutrient concentrations for all diets can be found in Table 1 from
representative samples taken throughout sample collection. Representative diets were
taken with each new bag of the LNSC pellet; therefore, 4 representative samples were taken
for each diet. All starch and sugar came from the same batch/lot number.
5.3.3

Study Design and Sample Collection

The study was carried out over a 12-week period (April – July 2021). Prior to
sample collection, horses were acclimated to pens (3.7 x 3.7 m) and were fed each diet
randomly over a 9-day period. Horses received 30% of each treatment diet during this
acclimation and stayed in pens for ~30 minutes. Sampling pens were adjacent to all horses’
home paddocks. Sampling collection occurred twice weekly with 8 horses sampled on day
1 and 8 horses on day 2. Four ID and four NID horses were sampled each day and treatment
diets were fed randomly across the sampling period. On the morning of the sampling day
(0700) horses were brought into their individual pens and 16-gauge x 14.6 cm (Covetrus)
catheters were placed under local anesthetic using aseptic technique. While in their
individual pens, horses had access to water, but no other feedstuffs. After catheter
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placement, horses underwent a 30-minute rest period before a blood sample (T0) was
collected (10 ML serum tubes; Covetrus) and the feed was offered. Diets were consumed
by all horses in ~10 minutes. Blood was collected at 30, 60, 75, 90, 105, 120, 150, 180,
210, and 240 minutes following complete consumption of the respective treatment diets.
Serum was allowed to clot for in a water bath (37 ̊ C) for 10 minutes and then centrifugated
at 800g x 10 minutes, aliquoted, and frozen at – 20 ̊ C for later determination of insulin
concentrations. Between sample collections, horses were housed in their home paddocks
where they had access to limited pasture forage (semi-dry lots), grass hay (11.85% CP,
0.6% starch, 5.9% WSC, 3.75% ESC, and 6.5% NSC on a DM basis), and water. All dietary
treatments and methods were approved by the University of Kentucky’s IACUC (#20203448).
5.3.4

Assays

Serum was analyzed for insulin by Cornell University’s Animal Health and
Diagnostic Center endocrinology laboratory via a human insulin RIA (EMD Millipore
Corp) and run-in duplicates 20. The sensitivity of the assay, as reported by the manufacturer
is 2.72 µIU/ML. The mean intra- and inter-assay coefficients of variation were 7.4% and
6.3%, respectively 20. If any insulin values were > 200 µIU/ML they were diluted using
assay buffer and re-run to obtain an accurate value.
5.3.5

Data Analysis

Statistics were run on Minitab Software 20.2 (Minitab LLC). To assess differences
between ID and NID horses’ insulinemic responses to all treatment diets, as well as within
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each metabolic group (ID vs. NID), incremental area under the curve for insulin (IAUCi)
was calculated for all dietary treatments and horses 110. A mixed effects model with random
factor of horse, fixed factors of dietary treatment and metabolic group, and response
variable of AUCi was run. Any differences were determined with a Tukey post-hoc test.
Statistical significance was considered at p<0.05 and a trend was considered at p<0.1.

5.4

Results
Within NID horses no significant differences were found between any diet IAUCi

(p>0.1) (Table 2). For the added sugar diets ID horses’ insulin responses were significantly
higher than their response to LNSC with Tx 6 and 7 (p<0.01) (Figure 1). In addition, the
response to TX6 was different than both TX2 and 4 and TX7 was different than TX4
(p<0.03). For the added starch diets, ID insulin responses were only significantly different
with Tx 8 compared to the LNSC (p<0.01) (Figure 2). In addition, the response to TX 8
was also different than TX 5 and 3 (p<0.02) and TX 5 was different than TX 3 (p=0.03).

5.5

Discussion
This study confirmed recent work

109

that recommendations for feeding ID horses

cannot be derived from the results of NID horses. NID animals in the current study did not
show any significant change in their insulin responses to feeding diets with increasing pure
added starch or sugar content, whereas ID animals did with an apparent threshold for a
significantly elevated response between 0.1-0.13 g NSC/Kg BW. If provided in more
complex feeds where the starch and sugar are not so potentially completely available for
digestion it might be predicted that a higher threshold of NSC may be found. Interestingly,
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however, the postulated threshold in this current study is very similar to the threshold of
Macon et al. [2021] (0.02 – 0.05 g starch/kg BW and 0.08 – 0.20 g NSC/kg BW) proposed
by the earlier study using individual feeds fed at slightly higher intake levels (1 – 1.25 g/kg
BW). Deliberately, in the current study we have provided the intakes of starch and sugar
and NSC on a g/kg BW intake basis rather than a % in the diet. This is because using the
% basis may be more misleading as higher intake levels of the same % diet than provided
here (1 g/kg BW) will provide more NSC per meal than the current study, which may
promote a higher insulin response. Certainly, we have previously reported that reducing
the meal size (0.5 g/kg BW) without changing the % NSC can promote a more normal
insulin responses 109.
Insulinemic responses to feeds and feedstuffs are dependent on several factors
including composition of the diet 48, rate of gastric emptying via meal size 111, consumption
rate

112

, as well as how insulin concentrations are determined

23

and the extent of any

incretin response 50. One aspect, of particular interest, is which component of NSC, starch
or sugar, is the main driver of the postprandial insulin response. Therefore, in the current
study we added pure sources of starch and sugar at increasing levels. Starch was derived
from an equal mixture of maize and oats, due in part to their use in the equine feed industry,
but also, because for this study pre-cecally available starch sources were required. Starch
is a polysaccharide composed of glucose in a linear polymer, amylose (less prececally
digestible form), and in a branched form, amylopectin (more prececally digestible form)
57,59

. Waxy-maize starch is almost entirely composed of amylopectin

113

, and therefore

should be a more prececally digested source of corn starch. Oat starch is 98-99% amylose
and amylopectin

58

and is very prececally available for digestion and absorption in the
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horse. Starch undergoes 2 cycles of digestion 1) pancreatic α-amylase hydrolyzes starch
yielding maltose, maltotriose and α-dextrins which are then 2) hydrolyzed by enzymes
along the brush border of the small intestine’s lumen into respective monosaccharides that
can be transported across the luminal and basolateral membrane and into circulation. With
the starch source in the current study being highly prececally digestible and given in a small
ration (0.63 + 0.16 kg), so not overwhelming the hydrolysable capacity of the small
intestine, it is assumed that LNSC absorbable glucose concentration <TX3 < TX5 < TX8.
The fold-increase in IAUCi in ID horses supports this being from LNSC to TX5: 1.7, LNSC
to TX8: 4.2, TX3 to TX8: 7.0, TX3 to TX 5: 3.1, and TX5 to TX8: 0.95. The differences
in insulinemic responses (TX3 vs. TX5, TX3 vs. TX8, and TX5 vs. TX8) to increasing
starch intake in the diets suggest a possible threshold for starch around 0.03 – 0.06 g of
starch/kg BW in addition to the core concentration of WSC (0.04 g/kg BW) provided by
the LNSC in ID horses.
However, increased insulinemic responses to starch diets could be due to abnormal
pancreatic enzyme secretion or function. Pancreatic steatosis, or fatty pancreas, has been
associated with the development of human metabolic syndrome 114, which shares similar
characteristics to EMS 2, including increased adiposity, hyperinsulinemia, tissue insulin
resistance, hypertriglyceridemia or dyslipidemia, hyperleptinemia, arterial hypertension,
and increased inflammation. Hyperinsulinemia has been shown to promote obesity in mice
by altering lipid metabolism

115

. Reynolds et al. (2019) showed that horses with

hyperinsulinemia had higher peri-renal and retroperitoneal adiposity and adipocyte
hypertrophy compared to healthy horses

116

. With abnormal lipid accumulation in the

pancreas negatively effecting insulin metabolism
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117-121

, hyperinsulinemia with

simultaneous pancreatic exocrine function could be seen in the ID horse. In Zucker rats,
lower pancreatic amylase was seen in obese rats with hyperinsulinemia compared to lean
rats 122. Therefore, if lipid infiltration of the pancreas occurred in study horses, differences
in insulinemic responses to starch diets could be due to overall metabolic dysfunction in
ID (i.e., hyperinsulinemia, obesity, and hepatic insulin resistance) 6.
For the added sugar diets, the ID horses had higher IAUCi for TX6 (0.11 g WSC/kg
BW) compared to TX4 (0.08 g WSC/kg BW). However, TX4 IAUCi was not statistically
different from the LNSC (0.04 g WSC/kg BW) IAUCi, but the TX6 insulin response was
higher compared to LNSC IAUCi (0.04 g of WSC/kg BW). This suggests a possible
threshold WSC between 0.08 – 0.11g/kg BW, which may be higher than the starch
threshold. Since the source of pure sugar was dextrose, this would result in quickly
available glucose, and possibly an enhanced incretin effect; therefore, one might have
predicted a potentially higher insulinemic response to sugar. The current study, however,
fed pure sources of highly prececally available starch which may explain the relatively
similar thresholds. When horses receive starch and sugar in normal diets, it is normally in
the form of a cereal grain, which must undergo significant digestion in comparison to the
powder fed in the current study. Some of the starch and sugar powder should have been
digested in the stomach by the mircoflora prior to the small intestine

59

. Therefore, ID

horses having a higher threshold for sugar compared to starch could be due to the
disappearance of more of the sugar in the stomach. Regardless, it is of interest to note that
despite being provided in a highly digestible and fermentable form there was considerable
insulin responses within 60-minutes in ID horses.
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Delta insulin (DI; [T60] – [T0] = [DI]) was calculated for all treatment diets. The OST,
used to categorize horses at the beginning of the study as ID and NID, roughly provides
0.15 g of WSC/kg BW 12 and produced a DI of 58.3 + 32.1 µIU/ML in ID horses. While
TX6 (0.11 g WSC/kg BW) and 7 (0.17 g WSC/kg BW) provided similar amounts of WSC
as the OST, they produced higher DI responses of 85.8 + 49.0 and 80.0 + 46.7 µIU/ML in
ID horses, respectively. Difference in insulinemic responses between the OST and TX6/7
could be due to rate of passage 48 and composition of the meal 111 or it could provide further
evidence that the apparent threshold for WSC in the ID horse is 0.11 g of WSC/kg BW.
Furthermore, TX6 and 7 produced similar DI and IAUCi responses, but TX7 did have
higher WSC and NSC content. Therefore, after 0.11 g of WSC/kg BW and with increasing
amounts of WSC, ID horses will have similar insulinemic responses.
It is important to recognize that the added starch and sugar were supplemented onto the
LNSC pellet that had a core WSC and starch content and it is possible that ID horses do
not have an individual threshold for starch and WSC, but for total NSC at 0.10 – 0.13 g/kg
BW when starch provides 0.06 + 0.008 g/kg BW and WSC provides 0.11 + 0.016 g/kg
BW. DI response was lower for TX5 (0.06 g starch/kg BW & 0.05 g WSC/kg BW) 58.6 +
56.6 µIU/ML compared to TX6 (0.11 g WSC/kg BW & 0.02 g starch/kg BW) 85.8 + 49.0
µIU/ML. In addition, TX5 IAUCi was 6,195 + 4,588 and TX6 was 9,025 + 6,212.
Due to the use of pure sources of sugar and starch, results from this study are not
completely transferrable to commercial equine feeds; although, interestingly similar
threshold levels were reported here as in the previous study using commercially available
feeds

109

. When developing dietary treatments several attempts were made to use whole

grains and commercial feeds; however, variability within individual dietary treatments
92

were too high especially with the low feed intakes. Due to the concentration of WSC and
starch proximity between diets, consistency was needed; therefore, pure sources of starch
and WSC were used. In both this and the previous study109 only low intake levels were fed
(~1 and 1.25g/kg BW) and these thresholds should be repeated in more animals and with
larger and smaller intakes to confirm that it is the amount of NSC in a meal that is key
rather than any effect of the actual meal size. In addition, these diets were only fed once to
each horse during the sample period; thus, only acute insulinemic responses were
quantified. IAUCi was calculated for insulinemic responses to accurately quantify the
insulinemic index of the feedstuffs fed

110

. This approach does not account for basal

hyperinsulinemia; therefore, a feedstuff that does not produce an exaggerated insulin
response may still increase the risk of HAL if basal hyperinsulinemia is present. Future
research should not only look at the quantity of rations being fed, but the effect on
insulinemic responses fed over a long period of time. Unpublished work in our lab has also
shown basal and post-OST insulin responses vary in respect to season, specifically in the
spring compared to fall and summer. Feeding concentrates in seasons that have higher
insulin concentrations (i.e., spring) could increase the incidence of HAL in ID horses. In
addition, basal hyperinsulinemia and post-OST insulin concentrations have been shown to
fluctuate significantly over a short period of time 64. These changes could be due to season,
individual horse variation in insulin response/concentrations, environmental factors,
pasture forage, bodyweight, and test/analysis. Multiple factors can influence the
postprandial insulinemic response and put ID horses at greater risk of HAL regardless of
NSC provided in a meal.
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Apparent thresholds witnessed in this study could be different compared to those in a
matrix feed. Within the current study, ID horses appear to have a threshold for total NSC
(0.11 – 0.13 g/kg BW) when starch provides 0.06 g/kg BW and WSC provides 0.11 g/kg
BW, suggesting that lower amounts of starch are needed to produce exacerbated
insulinemic responses in the ID horse compared to WSC. However, and unfortunately, an
additional starch treatment (0.08 g starch/kg BW) had been planned for but could not be
included due to errors in feed formulation; therefore, the apparent threshold for starch could
be equal to that of WSC. The NID horse has an upper limit for starch at > 1.1 g/kg BW 48,
which is 17-fold increase compared to the ID horse in the current study (0.06 g starch/kg
BW). ID horses may have different insulinemic responses compared to NID horses due to
differences in digestion and absorption of carbohydrates. Feeding recommendations for the
ID horse need to be revitalized. Future work should focus on meal size and long-term
feeding, in addition to NSC content provided, in order to decrease incidences of HAL in
the ID horse.
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Table 5.1. Dietary Treatments.
Treatment
CP %
WSC %
Diet

ESC %

Starch %

NSC %

LNSC

12.04 + 0.32

4.06 + 0.34

3.64 + 0.3

1.01 + 0.36

5.1 + 0.6

TX2

11.68 + 0.05

6.18 + 1.02

4.88 + 0.75

2.25 + 1.16

8.43 + 1.27

TX3

11.78 + 0.22

4.33 + 0.79

3.5 + 0.50

2.7 + 1.08

7.03 + 0.87

TX4

11.45 + 0.17

7.43 + 0.61

6.78 + 0.66

1.88 + 0.71

9.3 + 1.26

TX5

11.53 + 0.34

4.45 + 0.55

3.25 + 0.24

5.28 + 1.18

9.73 + 1.43

TX6

11.25 + 0.45

10.35 + 0.81

8.83 + 1.79

2.08 + 0.59

12.43 + 0.61

TX7

10.75 + 0.1

15.38 + 2.12

13.55 +
1.24

1.75 + 0.54

17.13 + 2.45

TX8

11.23 + 0.43

4.3 + 0.78

3.38 + 0.55

9.6 + 1.39

13.9 + 1.99

WSC

Starch

NSC

(g/kg BW)

(g/kg BW)

(g/kg BW)

LNSC

0.04 + 0.007

0.01 + 0.002

0.05 + 0.008

TX2

0.06 + 0.001

0.02 + 0.004

0.09 + 0.013

TX3

0.04 + 0.007

0.03 + 0.004

0.07 + 0.011

TX4

0.08 + 0.012

0.02 + 0.003

0.10 + 0.014

TX5

0.05 + 0.007

0.06 + 0.008

0.10 + 0.015

TX6

0.11 + 0.016

0.02 + 0.003

0.13 + 0.019

TX7

0.17 + 0.023

0.02 + 0.003

0.19 + 0.026

TX8

0.05 + 0.006

0.11 + 0.014

0.16 + 0.020

*All values presented on a dry matter basis
Values presented as mean + standard deviations.
Abbreviations: Crude protein (CP), water-soluble carbohydrates (WSC), ethanol-soluble
carbohydrates (ESC), non-structural carbohydrates (NSC), low non-structural
carbohydrate pellet (LNSC).
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Table 5.2. NID & ID Horse Numbers and IAUCi for all Dietary Treatments
Dietary Treatment
NID
ID
(g NSC/kg BW)

N

IAUCi

N

IAUCi

LNSC (0.05)

8

685 + 333 (730) D

6

2,326 + 1,048 (2,483) CD

TX2 (0.09)

8

701 + 370 (607) D

6

2,860 + 1,559 (2,787) CD

TX3 (0.07)

8

784 + 644 (838) D

6

1,499 + 426 (1,489) D

TX4 (0.1)

8

769 + 437 (556) D

6

4,258 + 1,910 (4,746) CD

TX5 (0.1)

8

981 + 635 (870) D

6

6,195 + 4,588 (7,867) BC

TX6 (0.13)

8

930 + 851 (816) D

6

9,025 + 6,134 (6,434) AB

TX7 (0.19)

8

1,475 + 1,010 (1,201) CD

6

10,781 + 6,212 (11,233) A

TX8 (0.16)

8

1,568 + 882 (1,214) CD

6

12,051 + 4,979 (12,541) A

Values presented at mean + SD (median)
Abbreviations: low-nonstructural carbohydrate pellet (LNSC), incremental area under the curve for insulin (IAUCi).
A, B, C, D
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Significant differences are denoted by means not sharing a letter

Figure 5.1. NID and ID IAUCi for LNSC and added Glucose Treatments.
LNSC: 0.04 g WSC kg/BW & 0.05 g NSC/kg BW. TX2: 0.06 g of WSC/kg BW & 0.09 g
NSC/kg BW. TX4: 0.08 g WSC/kg BW & 0.10 g NSC/kg BW. TX6: 0.11 g WSC/kg BW
& 0.13 g NSC/kg BW. TX7: 0.17 g WSC/kg BW & 0.19 g NSC/kg BW.
a, b
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Values that do not share a letter are statistically different.

Figure 5.2. NID and ID IAUCi for LNSC and added Starch Treatments.
LNSC: 0.01 g starch kg/BW & 0.05 g NSC/kg BW. TX3: 0.03 g starch/kg BW & 0.07 g
NSC/kg BW. TX5: 0.06 g starch/kg BW & 0.10 g NSC/kg BW. TX8: 0.11 g starch/kg BW
& 0.16 g NSC/kg BW.
a, b, c, d

Values that do not share a letter are statistically different.
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CHAPTER 6.

CONCLUSIONS AND FUTURE DIRECTIONS

Laminitis is a debilitating and often results in euthanasia. Endocrinopathic laminitis is
the most common form of laminitis123 and has a recurrence rate of 34.1% with an increased
risk posed in animals with hyperinsulinemia67. Circulating insulin concentrations are
shown to be an integral aspect of endocrinopathic laminitis22; therefore, management of
the hyperinsulinemic state is crucial for reducing the incidence of endocrinopathic
laminitis. While prevalence of ID in horses has not been assessed, basal and postprandial
hyperinsulinemia is a known aspect of ID6. Thus, diagnostic tests should focus on correctly
identifying the ID horse and nutritional management practices should focus on reducing
hyperinsulinemia. The overall objective of this work was to improve the current diagnostic
test, the OST, and add to our understanding, as well as improving nutritional management
practices for the ID horse.
Based on our seasonal work (Chapter 2), ID horses’ experience seasonal fluctuations
in both basal and post-OST insulin; however, the driver for those fluctuations remains
elusive. While body morphometrics and supplemented forage were analyzed as possible
factors affecting serum insulin concentrations, our work did not find conclusive evidence
of one driver. Instead, it is our belief that there are multiple factors that influence both basal
and the post-OST response, and those factors are primarily due to the environment. Pasture
forage has often been theorized to cause seasonal fluctuations in circulating insulin
concentrations in the healthy and ID horse

6,33-37

. Most of these studies find peaks of

insulin concentrations in various seasons, with only a few studies finding the same seasonal
trends. We found that ID horses have higher insulin concentrations in the spring and winter
and the lowest in the fall. Our findings, however, partially contradict current theories that
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ID animals are at higher risk for endocrinopathic laminitis in the fall. In the ID pony33,
greater insulin responses while ponies were on pasture were seen after feeding glucose in
the fall compared to other seasons. Authors suggested that this could be due to variability
in insulinemic responses33. Indeed, variation in insulinemic responses in the ID horse has
been well documented 10,19,21,41,65 and the source of that variation could be due to several
factors. In future studies, comparing ID horses on pasture to those on a dry lot could reveal
the potential impact that pasture forage has on seasonal insulin concentrations. Outside of
environmental factors, a metabolic shift could also be the cause of seasonal insulin
fluctuations. This metabolic shift is most likely due to maintaining energy balance
throughout the year, as well as an instinctual habits to prepare for food scarcity in winter.
The role of circulating insulin in this metabolic shift is presumed to be very influential, due
to insulins role in fat storage, maintaining energy balance, and shuttling the body’s fuel
sources. However, designing a study to research a metabolic shift that may be causing
seasonal fluctuations in insulin in an ID horse would be extremely controlled and most
likely not practical. Due to ID’s relationship with hypertriglyceridemia and adipose tissue’s
endocrine function; further investigation of fat digestion and storage in both the healthy
and ID horse could elucidate the metabolic shift and would aid in our understanding of this
complex metabolic dysfunction. With seasonal circulating insulin fluctuations, some
seasons (i.e., the spring and winter) are more dangerous for the ID horse due to the
increased risk for endocrinopathic laminitis or HAL. Therefore, veterinarians and owners
should know their ID horses’ endocrine status throughout the year. Often, veterinarians
will tell owners to know their horse(s) normal vital signs, which could aid in the
identification of pain or discomfort. Hopefully, veterinarians and owners alike will find the
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importance of knowing their ID horse(s) normal insulin concentrations throughout the year,
which will help them in identifying when their horse is at the highest risk of HAL.
The OST is the most frequently used diagnostic tool for ID in the horse; however, little
work has been conducted to elucidate factors affecting the outcomes of the OST in the ID
horse prior to our work. This work showed that basal insulin concentrations are not an ideal
diagnostic tool for the ID horse, which has also been shown by others14,16,17. In addition,
our work compliments the work completed in ponies21 that indicated similar results would
be obtained whether the horse was fasted or sample directly off pasture for the OST in the
ID horse. However, we did not find the same result for increasing the oral sugar dose 17. In
the pony, the higher dose produced a greater insulinemic response compared to the lower
dose, but our work showed no difference between the low and high dose for the OST in ID
horses. In addition, some ID horses were unable to be identified by either the low or high
dose OST. This could indicate that some horses require an even greater amount of glucose
compared to the pony or individual variation in insulin responses. Future work should look
at even higher doses of Karo Light Corn Syrup or using another feedstuff that is denser in
hydrolysable sugar or even perhaps starch.
Insulinemic responses to NSC (i.e., sugar and starch) have recently been found to be
the best predictor of laminitis risk13. Prior to our work, little was known about the
postprandial insulinemic response to NSC in the ID horse, except for work conducted in
ID ponies being fed forage

61

and ID horses being fed a high protein meal62. In fact,

recommendations for feeding the ID horse originated outside of the ID model47, in horses
diagnosed with polysaccharide storage myopathy. Therefore, this is the first nutritional
work that has been completed in the naturally occurring model of the ID horse. Our findings
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have shown that ID horses’ response is very different from that of the NID horse; thus,
future work and recommendations should not originate outside the ID model. While
carbohydrate metabolism has been investigated in the healthy horse, no work has been
completed in the ID horse. Ideally, future research in the ID horse should continue to
determine safe thresholds for all nutrient types (i.e., crude protein, fat and NSC), but it
should also investigate the potential differences in carbohydrate metabolism and overall
gastrointestinal physiology between that of the healthy and ID horse. Differences in
incretin concentrations have already been seen between healthy and ID ponies grazing
pasture 124. Furthermore, our study found that ID horses potentially have a lower threshold
for starch than simple sugars. This could indicate potential alterations in pancreatic
enzymes, glucose disposal, or insulin clearance. Alterations in the metabolism and/or
functionality of the pancreas and liver have been discussed in the ID equid6; however, no
further work has been completed in this area. Future work should examine potential
abnormalities in the pancreas and liver of the ID horse compared to the healthy horse. That
information could help with our understanding of this complex metabolic disorder and
further improve how we diagnosis, manage and treat the ID horse.
While our work has shown an apparent threshold for NSC in the ID horse, only
concentrates with pure sources of NSC were used. Current nutritional management
recommendations for ID horses are to manage them on a ration balancer with a low-NSC
forage125. Thus, it would be prudent to understand insulinemic responses to forages in the
ID horse. In concentrates, Loos et al. found that a high protein meal resulted in an
exaggerated insulin response62 in the ID horse. Our work showed that reducing a ration
balancer by half the amount will result in a normal postprandial insulinemic response in
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the ID horse. However, insulinemic responses to forages have not been examined in the ID
horse but have in the ID pony61. Our lab is now investigating the effects of forage pellets
on insulinemic responses in the ID horse; however, future work should also investigate
insulinemic responses to long-stem forage. Additionally, some ID horses with concurrent
PPID or lean-type ID only horses have issues maintaining and gaining weight. Therefore,
nutritional studies need to be conducted in these difficult to manage cases.
HAL is the main concern in the ID equid. In all our work, no treatment induced HAL;
however, some horses showed both basal and postprandial insulin concentrations near this
proposed threshold90. HAL does not occur within a few hours. Research has shown that
continuous hyperinsulinemia needs to be present to induce HAL4. Only acute insulinemic
responses to feedstuffs have been examined in the ID horse and pony. Thus, future work
should investigate long-term feeding of concentrates on incidence of HAL. However, this
is not to say that HAL will not occur after the feeding of a meal. For example, if an ID
horse or pony has chronic hyperinsulinemia exacerbated by the environment (e.g., stress,
pasture forage, etc.) and then a meal is fed, that can cause circulating insulin to increase
more and that may induce a HAL episode. This could occur in a specific season, like the
spring, when basal insulin is already high in the ID horse.
Overall, this work has advanced our knowledge on the seasonality of insulin, created
new avenues for future work on the OST, and has laid the foundation for research backed
nutritional recommendations for the ID horse. As always, there is more work to be
completed, but perhaps, even more importantly, research should take a step back and
examine the overall differences between that of the ID horse and healthy horse in regard to
gastrointestinal physiology, metabolism of nutrients, and insulin secretion and clearance.
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Based on this work, the most important idea that was learned, was that every ID horse
needs to be treated individually. No general assumptions can be made about individual ID
horses. Veterinarians and owners should take great care when treating these equids with
complex metabolic dysfunctions, whose pathogenesis remains elusive.
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APPENDIX
A. Introduction
The enteroinsular axis has been well established in the horse4, which includes the
response of the gastrointestinal hormones after oral consumption of feedstuffs.
Specifically, the incretin hormones, glucagon-like peptide-1 (GLP-1) and glucose
dependent insulinotropic polypeptide (GIP), have been examined in the horse 36,37.
The incretin response accounts for two-thirds of glucose disposal after meal
consumption50; therefore, they are integral for insulin secretion postprandially. Thus,
we conducted a small pilot study to examine the effects of varying starch and sugar
on insulin, glucose, and active GLP-1.
B. Design
Samples were taken from a previous study. Four horses (n=3 ID and n=1 NID)
had their insulin, glucose and active GLP-1 measured after the consumption of LNSC
(12% CP, 5.1% NSC, 4% NSC, and 1% starch), TX4 (11.5% CP, 9.3% NSC, 7.4%
WSC, 1.9% starch), and TX8 (10.8% CP, 17.1% NSC, 15.3% WSC, 1.8% starch).
Samples were taken prior to feeding (0 minutes) and at 30, 60, 75, 90, 105, 120, 150
and 180 minutes postprandially. Serum samples were allowed time to clot,
centrifugated at 800g x 10 minutes, aliquoted, and frozen at -20 ̊ C for later
determination of insulin. Glucose samples were collected in plasma blood tubes and
were put on ice after blood collection, centrifugated at 800g x 10 minutes, aliquoted,
and frozen at -20 ̊ C. GLP-1 samples were also collected in plasma blood tubes, but
they were stored on ice prior to blood collection and placed immediately back on ice
after blood collection. GLP-1 samples were processed within an hour after collection,
centrifugated at 1500g x 10 minutes, aliquoted, and stored at – 80 ̊ C. Cornell AHDC
endocrinology laboratory measured insulin via a human RIA and glucose was
measured by colorimetric assay. Active GLP-1 was measured via ELISA (Millipore).
C. Results & Discussion
Due to lack of horses used, statistics could not be done; therefore, general
observations were made. The NID horse responded the lowest compared to the ID
105

horses for insulin, glucose, and GLP-1. For ID horses, TX8 elicited the greatest
insulinemic and glycemic response (Figure A.1 & A.2); however, that was not the
case for GLP-1 (Figure A.3). For TX4 (15.6 pM) and 8 (13.1 pM) basal GLP-1 was
elevated, but then decreased drastically after meal consumption. Whereas the LNSC
dietary treatment started at a similar basal concentration (16.2 pM) but increased
further after meal consumption.
GLP-1 concentrations only increased after consumption of the LNSC dietary
treatment, which could be because it was a pellet compared to the other treatment
diets that fed a pure source of sugar. This pure source of sugar could have been
fermented in the stomach or not have triggered the incretin response. In addition, the
basal GLP-1 levels were higher in the ID animals compared to the NID animal (9.3
pM). This could be due to the consumption of pasture prior to sample collection.
Therefore, ID horses had already triggered the incretin response by consuming fresh
pasture and/or supplemented hay prior to sample collection leading to an elevated
basal incretin response. Thus, once the incretin response has been triggered by the
oral consumption of feedstuffs, it cannot be exaggerated further.
Unfortunately, not fasting prior to sample collection yielded exaggerated basal
GLP-1 concentrations, which are unable to be differentiated after dietary treatments.
In future studies, horses should be fasted or not sampled directly off pasture to allow
incretin levels to return to basal levels to be able to determine dietary effects on the
incretin response. In addition, protease inhibitors were not used when samples were
collected; however, samples were collected and processed quickly and remained on
ice to decrease degradation of GLP-1.
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Figure A.1. Insulin responses of the NID and ID horses.
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Figure A.2. Glucose responses of the NID and ID horses.
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